-------
IV. RESULTS
Application of the peak identification procedure to the FY82 compos-
ites as described above resulted in the following tables of results. Twelve
tables (Tables 1 through 12) are provided in this report which list_all NBS_
identified compounds from the three composite data sets as well as information
regarding peaks still unidentified. An additional six tables (Tables A-l to
A-6) are provided in Appendix A (Volume II) to this report which include more
detailed information regarding the incidence of occurrence of peaks in the
three data sets.
Tables 1 through 3 present the compounds identified via comparison
to NBS reference spectra for the volatile, 6% Florisil semivolatile, and
15/50% Florisil semivoiatile samples, respectively. Each table consists of
the following information in columnar form. The first column shows an index
number, which is simply a sequential numbering of the compounds listed in the
table. The index number is not related to any other numbering order in pre-
vious reports. The Compound Class column indicates the chemical class to
which a compound belongs. Chemical class designations were determined by
manual inspection of the compound names. The Compound Name, Formula, and
CAS No. columns are derived from the NBS library resident on the Incos data
system. In most cases, the names are unaltered from the name in the NBS li-
brary. In some cases, however, the peak identification procedure was unable
to accurately specify a positional isomer, and the positional portion of the
NBS name was either removed or placed in parentheses. For compounds with
positional designations in parentheses, the corresponding CAS number refers
to the given isomer. The remaining columns show the frequency of occurrence
of the listed compounds within the three tested age groups: 0-14, 15-44, and
45+ yr.
Tables 4 through 6 show the same information as Tables 1 through 3,
with the exception that frequency of occurrence data are arranged according
to census region [North Central (NC); Northeast (NE), South (S), and West (W)].
Information regarding age groups is not given. The three tables represent
data for the volatile, 6%, and 15/50% Florisil fractions, respectively.
Tables 7 through 9 show the frequency of occurrence data for peaks
which ACORN was unable to identify from the NBS library. As with the previous
sets of tables, Tables 7 through 9 represent data compiled from the volatile,
6%, and 15/50% Florisil fractions, respectively. The list of entries is
sorted by descending frequency of occurrence. Occurrence data are also listed
for each census region.
Tables 10 through 12 represent the degree to which the unknown peaks
in the FY82 data were identified, and thus may be considered "peak inventories"
for the analyzed data. The tables list the number of peaks selected for analy-
sis for each of the composites in this study, the number of peaks identified
by ACORN from comparison to the NBS library, the number of peaks which remain
unidentified, and the number of compounds identified and quantitated in the
target compound search previously reported (Stanley 1986b, Stanley 1986c).
Thfs information provides a general guide for the amount of work which re-
mains to be done for complete characterization of the composite samples.
18
-------
Table 1. Compounds Tentatively Identified in the Volatile Organic Analysis
Data Set vs. Frequency/Age Group
Index
IS.
1
2
3
4
. 5
* 6
7
8
9
" 10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
33
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
* 56
57
58
59
•i. 60
61
62
63
64
Ccmpounddass Compound Name (a)
Internal Standard Bromochloropropane - Internal Standard
Carbon Dioxide Carbon dioxide
Alkane 2-Methyl-butane
Unidentified C5.H10 [Cyclopentane]
C3 Substituted cyclopropane [Propyi-cyclopropana]
C3 Substituted cyclopropane [Propyl-cyclopropane]
2,3-Dimethyl-hexane
1 ,2-Diethyl-cyclobutane
Alkane 2 C10(Decane]
C10 Alkane [2-Methyl-nonane]
2,2,3,3-Tetramethyl-hexane
Sat alkane > C1 1 [2-Methy Wecane]
Alkyl substituted hexane (Pentyl-cydohexanel
2,2-OimethyWecane
G13 Alkane [3,3-Oimethyl-undecanej
Alkane [6-Ethyl-2-methy!-decana|
Alkane [2,6,7-Trimethyl-decanej
Alkane 2 C11 [5-(1-Methylpropyl)-nonane]
C13 Alkane (2,2,7-Trimethy Wecane]
3,3,8-Trimethyl-decane
Alkane [6-Methyl-tridecane]
Alkene C5 Alkane [1 -Pentene]
1-Hexene
Unidentified C6.H12 [1-Hexene]
3-MethyM ,4-heptadiene
1,6-Octadiene
1 ,3,6-Octatriene
Unidentified C8.H12 [3-Ethylidene-1-methyl-cyclopentene]
1-Nonene
3-Ethyl-2-methyl-1 ,3-hexadiene
C10 Ringed alkene [1.7.7-Trimetnyl-bicyclo[2.2.1]hept-2-ene]
1 -Methyl-4-(1 -methylethenyl)-cydohexene
7-{1-Methylethylidene)-bicyc!o[4.1.0] heptane
C11 Alkene [1-Undecene]
C11 Alkene [1-Ethenyl-2-hexenyl-cydopropane]
Isomer of Undecen-3-yne [5-Undec-3-yne]
Isomer of Undecen-3-yne [5-Undec-3-yne]
Arene C2 Alkyl benzene [1,2-Dimethyl-benzene]
C2 Alkyl benzene [1 ,2-Dimethyl-benzene]
C3 Alkyl benzene [1,2,4-Trimethyl-benzen9]
C3 Alkyl benzene [1 -Methylethyl-benzene]
Propyl-benzene
C3 Alkyl benzene [1-Methyl-2-ethyl benzene]
Isomer of tetramethyl benzene [1,2,3,4-Tetramethyl-benzene]
1-Methyl-3-(1-methylethyl-) benzene
Naphthalene
1-Ethylprapyl-benzene
Aliphatic Alcohol 3-Methyl-1 -butanol
1-Hexand
Isomer of ethyl hexanol [3-Methyl-1 -hexanoi]
2-Ethyl-1-Hexanol
Isomer of odanol [1 -Octanol]
Isomer ofoctanol f1-0ctanoi]
Unidentified C13.H28.0 [1-Tridecanol]
Unsaturated Alcohol Isomer of Octen-ol [3-Octen-2-oi]
Isomer of Octen-ol [3-Ocien-2-oi]
Aliphatic Aldehyde Unidentified C5.H10.0 [Pentanal]
Unidentifed C6.H12.0 [Hexanal]
C7 Aldehyde [Heptanal]
Nonanal
Decanal
Unsaturated Aldehyde 2-Methyl-propenal
Isomer of Hexenal [2-Hexenal]
Isomer of Hexenal [2-Hexenal]
C7 Unsat aldehyde [2-Heptenal]
Corrpctmd
Formula (b)
-
C.02
C5.H12
C5.H10
C6.H12
C6.H12
C3.H18
C3.H16
C10.H22
C10.H22
C10.H22
C11.H24
C11.H22
C1iH26
C13.H28
C13.H28
C13.H28
C13.H28
C13.H28
C13.H28
C14.H30
CS.H10
cam 2
C6.H12
C8.H14
CS.H14
C8.H12
C8.H12
C9.H18
C9.H16
C10.H16
C10.H16
C10.H16
C11.H22
C11.H8
C11.H18
C11.H18
C8.H10
C8.H10
C9.H12
C9.H12
C9.H1 2
C9.H1 2
C10.H14
C10.H14
C10.H8
C11.H16
C5.H12.0
C6.H14.0
C7.H16.0
C3.H18.0
cam 8.0
C3.H1 8.0
C13.H28.0
cam 6.0
cam 6.0
C5.H10.0
C6.H1ZO
C7.H14.0
C9.H18.0
C10.H20.0
C4.H6.0
03.H10.0
O3.H10.0
C7.H1ZO
Compound
CAS No. (G)
124-38-9
78-78-4
287-92-3
2415-72-7
2415-72-7
584-94-1
61141-83-1
124-18-5
871-83-0
13475-81-5
6975-98-0
4292-92-6
1 7302-37-3
17312-65-1
62108-21-8
62108-25-2
62185-54-0
62237-99-4
62338-16-3
13287-21-3
109-67-1
592-41-6
592-41-6
1603-01-6
3710-41-6
22038-69-3
62338-00-5
124-11-8
61142-36-7
464-17-5
5989-54-8
53282-47-6
821-95^
22822-99-7
74744-31-3
74744-31-3
95-47-6
95-47-6
95-63-6
98-82-8
103-65-1
611-14-3
488-23-3
535-77<3
91-20-3
1196-58-3
• 123-51-3
111-27-3
13231-81-7
104-76-7
111-87-5
111-37-5
112-70-9
57648-55-2
57648-55-2
110-62-3
66-25-1
111-71-7
124-19-6
112-31-2
78-55-3
6728-26-3
6728-26-3
1 8829-55-5
Number of Occurrences
In All In Each Age Group
Sarrctes 0-14 15-44 45+
46
45
18
7
13
22
31
3
18
9
10
6
1
13
1
3
21
1
10
1
4
4
15
24
4
4
10
1
8
44
44
1
1
8
2
17
31 •
41
16
2
1
8
3
1
2
1
1
29
1
3
7
12
29
1
2
15
46
45
46
46
43
1
21
32
46
12
12
6
3
2
3
6
2
4
2
1
1
0
4
0
2
3
0
2
0
1
1
7
6
0
3
3
0
2
12
10
1
0
3
0
4
8
9
2
0
0
0
0
0
0
0
0
7
0
1
1
4
9
0
0
3
12
12
12
12
11
1
5
10
12
17
17
6
3
7
8
14
1
4
3
2
5
0
4
0
3
7
0
4
0
1
0
5
9
0
1
1
0
4
17
17
0
0
5
0
4
12
• 16
7
1
1
5
2
1
1
1
1
12
1
1
4
4
11
0
1
5
17
17
17
17
17
0
7
12
17
17
16
6
1
4
11
11
0
3
4
7
0
1
5
1
3
11
1
4
1
2
3
3
9
4
0
6
1
2
15
17
0
1
0
2
9
11
16
7
1
0
3
1
0
1
0
0
10
0
1
2
4
9
1
1
7
17
16
17
17
15
0
9
10
17
19
-------
Table 1 (concluded)
ndax
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
30
3t
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
t17
118
119
120
121
Compound Class
Aliphatic Ketona
Unsaturatad Ketone
Aliphatic Ether
Aliphatic Ester
,
Unsalurated Ester
Haiocarbon
Phenol
Haiorocyc'a
Suifida
Organo-SBicon
Compound Name (a)
C7 Unsat aldehyde [2-HeptenaJ]
2,4-Heptadienal
2,4-Nonadienal
Isomerof decenal [2-DecsnaJ]
Isomerof decenal [2-Decenai]
UnsaL aldehyde [2-Decsnal]
Unsat. aldehyde [2-Decsnai]
Unsat aldehyde [2-Oecenal]
Diene aldehyde [2,4-Decaaienai]
Diena aldehyde [2,4-Decadienaij
Diene aldehyde [2,4-Dodecadienal]
C7 Ketone (2-Heptanone]
4-Heptanone
Unidentified C7.H12.0 [2.2.3-Trimetriyl-cyciobutanone]
C8 Ketone [3-Octanonej
Sat. ketone [2-Oecanone]
Isomer of Octen-one (3-Oc:en-2-onej
08 Ketona [3-Oc:en-1-one]
3,5-Octadien-2-one
C9 UnsaL ketone [3-Nonen-2-one]
Olmeihoxy methane
Propanoic acid, ethyl ester
05 Methyl ester [Butanoic acid, methyl ester]
Propanoic add, propyl ester
Pentanoic add, methyl ester
07 Methyl ester [Hexanoic add, methyl ester]
3-Methyl butanoic add, ethyl ester
Propanoic add, butyl ester
2-Methyl propanoic acid, 1-methylethyl ester
Acetic acid, pentyl ester
2-Methyl butanoic acid, ethyl estar
08 Ethyl ester [Hexanoic add, ethyl ester]
Acetic add, hexyl ester
08 Ester [3-Methyl butanoic acid, propyl ester]
08 Ester [Butanoic acid, 1-Methylpropyl ester]
08 Ester [Butanoic acid, 1-Methylpropyl ester]
Octanoic add, methyl ester
Hexanoic add, 1-methy!ethyl ester
Butanoic acid, pentyl ester
Hexanoic acid, 2-methylpropyl ester
Octanoic add, ethyl ester
010 Ester [2-Methyl-propanoic acid, hexyl ester]
011 Ester [Hexanoic add, pentyl ester]
011 Ester [4-Methyl pentanoic add, pentyl ester]
011 Ester [Hexanoic acid, 2-Methylbutyl ester]
Isomer of octanoic add [3-Methyl-butyl ester]
3-Octen-1-ol, acetate
05 Bromoalkana [1-Bromopentane]
3-Bromo-Pentane
Brominated alkane 5 07 [1-Bromo-heptane]
Dichlorobutar.a [1,4-dichlorobutane]
2-8romo-2-chloro-1 ,1 .trifluoro-ethane
tsomer of einyl-ohenol [4-Elhyl-onenol]
Unidentified C9.H14.0 [2-Pentyi-iuranl
Dimethyl disuifide
Dimethyl trisulfia'e
Decamethyl-cydopentasiloxane
Corrpound
Formula (b)
C7.H1ZO
C7.H10.0
C9.H14.0
C10.H18.0
C10.H18.0
C10.H18.0
C10.H18.0
C10.H18.0
C10.H16.0
C10.H16.0
C12.H20.0
C7.H14.0
C7.H14.0
C7.H12.0
C3.H16.0
C10.H20.0
C3.H14.0
C8.H14.0
C8.H1ZO
C9.H16.0
C3.H8.02
C5.H10.02
C5.H10.02
C6.H12.02
C6.H12.02
C7.H14.02
C7.H14.02
C7.H14.02
C7.H14.02
C7.H14.02
C7.H14.02
C8.H16.02
C8.H16.02
C8.H16.02
C8.H16.02
C8.H16.02
C9.H18.02
C9.H18.02
C9.H18.02
C10.H20.02
C10.H20.02
C10.H20.02
C11.H22.02
C11.H22.02
C11.H22.02
C13.H26.02
C10.H18.02
CS.H11.BR
C5.H11.BR
C7.H15.BR
C4.H8.CL2
C2.H.CL8R.F3
C3.H10.0
C3.H14.0
CZH6.S2
C2.H6.S3
C10.H30.05.SI5
Ccrrpcund
CAS No. fcl
57266-86-1
4313-03-5
6750-03-4
3913-81-3
3913-81-3
3913-81-3
3913-81-3
3913-81-3
25152-84-5
25152-84-5
21662-16-8
11043-0
123-19-3
1449-49-6
106-58-3
393-54-9
1669-44-9
1669-44-9
30086-02-3
14309-57-0
109-87-5
105-37-3
623-42-7
106-36-5
624-24-8
106-70-7
108-64-5
590-01-2
617-50-5
628-63-7
7452-79-1
123-66-0
142-92-7
557-00-6
819-97-6
819-97-6
111-11-5
2311-46-8
540-18-1
105-79-3
106-32-1
2349-07-7
540-07-8
25415-71-8
2601-13-0
2035-99-6
69668-83-3
110-53-2
1809-10-5
629-04-9
110-56-5
151-67-7
123-07-9
3777-69-3
824-92-0
3658-80-8
541-02-6
In All
Sarrdes
23
32
29
1
25
28
29
45
1
15
26
36
35
7
1
1
3
37
8
25
1
29
3
7
1
42
16
2
4
3
5
12
16
7
1
4
27
1
17
1
36
12
24
6
4
24
1
3
3
2
2
16
8
29
27
2
28
In Each Age Group
0-14 15-44 45+
8
6 '
10
1
5
9
9
12
. 1
• 6
' 6
9
10
1
0
1
0
11
3
10
0
4
1
0
0
11
4
0
0
1
0
4
5
1
0
0
11
0
6
0
10
3
8
1
1
7
1
2
1
1
0
3
4
11
4
0
4
6
11
11 .
0
10
11
12
17
0
4
10
• 13
12
5
0
0
5
13
3
6
0
' 12
0
3
0
17
5
0
3
1
2
2
5
3
1
3
9
1
9
0
14
3
9
2
3
9
0
0
1
1
1
7
0
9
12
0
11
9
15
8
0
10
8
8
16
0
5
10
14
13
1
1
0
4
13
2
9
1
13
2
4
1
14
7-
2
1
1
3
6
6
3
0
1
7
0
2
1
12
6
7
3
0
8
0
1
1
0
1
3
2
9
11
2
13
(a) Tentative compound identification is based on search vs. the NBS mass spectral library. Confirmation has not been achieved by comparing
retention with an authentic standard. In cases where more than one reference compound successfully matched the unknown spectrum,
a general descriptive name is reported and the best ranked NBS name is provided in brackets.
(b) ki cases where both a general name and an NBS name is reported, the formula corresponds to the NBS name and may not be applicable to the general name.
(c) In cases where both a general name and an NBS name is reported, the CAS no. corresponds to the NBS name.
20
-------
Table 2. Compounds Tentatively Identified in the 5% Florisil Semivolatile Organic
Analysis Data Set vs. Frequency/Age Group
Index
I.S.
1
2
3
4
5
6
7
3
9
10
^ 11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
• 59
60
61
62
63
64
Ccmcound Class
Internal Standard
Alkane
Saturated Ketone
Saturated Ester
Sulfide
Dipeptide
Alkene
Unsaturated Aldehyde
Unsaturated Amine
Unsaturated Ketone
Arene
Aromatic Aldehyde
Aromatic Ketone
Phenol
Aromatic Ester
Aromatic Ether
Aromatic Amine
Aromatic Oxime
Thiocyanic Ester
Heterocyclic Compound
Steroid
Corroound (a)
D10-Anthracene ,•; .p
2,6,10,14-Tetramethyl-hexadecane
2,6,10,1 4-Tetramethyl-nonadecane
Alkane SC18 [2,6,10,14,19-Pentamethyl eicosane]
1 ,2,4-Cyclopentatrione
12-Methyl-tridecanoic add, methyl ester
Nonanedioic add, bis(l-methylpropyl) ester
9-Octadecenoic acid, ethyl ester
Methyl 2-methyl-1 -(methylthio)butyl disuifide
Dimethyl trisulfide
Glydne, anhydride
C5 Substituted naphthalene
[Octahydro-tetramethyl-1H-cyclopropan(A]naphthalene]
Hexahya'ro-4,7-dimethyl-1-(1-methylethyl)-naphthalene...
5-Elhyiidene-1 -methyl-cycioheptene
C30 Unsat hydrocarbon [Hexamethyl-tetracosahexaenej
Ylangene
2-8utyl-2-octenal
Unidentified C9.H8.0 [Cycloociatetraene-1-carboxaldehyce]
N,N-Dimethyl-3-octen-2-amine
6, 1 0-Dimethyl-5,9-undecadien-2-one
C4 Alkyl benzene [1-Ethyl-2,3-dimethyl benzene]
2-Ethyl-1 ,3-dimethyl-benzene
C4 Alkyl benzene [4-Ethyl-1 ,2-dimethyl-benzene]
C4 Alkyl benzene [Diethyl benzene]
C4 Alkyl benzene [Methyl(1-methylethyl)-benzene]
Cydohexyl-benzene
C3 Alkyi benzene [1,3,5-Trimethyl-benzene]
C4 Alkyl benzene [1-Ethyl-2,3-dimethyl benzene]
C5 Alkyl benzene [1-Ethyl-4-(1-methylethyl)-benzene]
C3 Alkyl benzene [1-Elhyl-3-methyl-benzene]
C3 Alkyl benzene [l-Ethyl-2-methyl-benzene]
C3 Alkyl benzene [1 ,3,5-Trimethyl-benzene
C3 Alkyi benzene [1 ,3,5-Trimethyl-benzene
C4 Alkyl benzene (1-Elhyl-2,4-dimethyl-benzenej
2-Methyl-naphthalene
Unidentified C10.H12 [2,3-Dihydro-1-methyl-1H-lndene]
Unid. C15.H24 [Hexahydro-tetramethyl-benzocydoheptene]
UnsaL C4alkyl benzene [4-Ethenyl-1,2-dimethyl-benzene]
2-Propenyl-benzene
Benzaldenyde
4-Pentyl-benzaldehyde
Unidentified C9.H8.0 [2,3-Dihydro-1H-lnden-1-one]
1-Phenyl-ethanone
2,6-Bis(1,1-dimethylethyl)-4-methyl-phenol
[1,1'-Biphenyl]-2-ol
2,2'-Methylenebis[6-(1 , 1 -dimethylethyl)-4-methyl-phenol
Benzenepropanoic add, ethyl ester
1,1'-0xybis-benzene
1 -Methoxy-4-(1 -propenylj-benzene
C2 Alkyl benzenamine [3,5-Oimethyl-benzenamine]
4-Methyl benzaldehyde, oxime
Thiocyanic add, phenyl ester
2,3,5-Trimethyl-1 H-oyrrole
Unidentified C3.H7.N f1H-lndoie]
Unidentified C8.H7.N [Indolizine]
2-(Methylthio)-benzothiazoie
5-(2-Propenyl)-1 ,3-8enzodioxoie
1 ,4-Dioxaspiro(4.6]undec-7-ene
2,4-Dihydro-2,5-dimethyl-3H-pyrazol-3-one
5,5-Diethyl-2,4-imidazolidinedione
(5.Alpha)-cholest-3-ene
(3.Beta.)- Cholest-5-en-3-ol acetate
Cholest-5-en-3-ol- (3. beta.)-, propanoate
Cholest-5-en-3-one
Cholest-5-ene
Formula (b)
C20.H42
C23.H48
C25.H52
C5.H4.O3
C15.H30.02
C17.H32.04
C20.H38.02
C7.H16.S3
C2.H6.S3
C4.H8.03.N2
C15.H24
C1S.H24
C10.H16
C30.H50
C15.H24
C12.H22.0
C9.H8.0
C10.H21.N
C13.H22.0
C10.H14
C10.H14
C10.H14
C10.H14
C10.H14
C1ZH16
C9.H12
C10.H14
C11.H16
C9.H12
C9.H12
C9.H12
C9.H12
C10.H14
C11.H10
C10.H12
C15.H24
C10.H12
C9.H10
C7.HaO
C1ZH16.0
C9.H8.0
caHao
C15.H24.0
C12.H10.0
C23.H3Z02
C11.H14.02
C1ZH10.0
C10.H12.0
C8.H11.N
C3.H9.0.N
C7.H5.N.S
C7.H11.N
C8.H7.N
C3.H7.N
C8.H7.N.S2
C10.H10.02
C9.H14.02
CS.H8.0.N2
C7.H12.02.N2
C27.H46
C29.H48.02
C30.H50.02
C27.H44.0
C27.H46
AS Number (cl
638-36-8
55124-80-6
52268-60-5
15849-14-6
5129-58-8
57983-36-5
111-62-6
69078-83-7
3658-80-8
4202-74-8
1 7334-55-3
183-76-1
15402-94-5
H1-02-4
14912-44-3
13019-16-4
30844-12-3
55956-31-5
3796-70-1
933-98-2
2870-04-4
934-80-5
25340-17-4
25155-15-1 '
827-52-1
108-67-8
933-98-2
4218-48-8
620-14-4
611-14-3
108-67-8
108-67-8
874-41-9
91-57-6
767-58-8
1461-03-6
27831-13-6
300-57-2
100-52-7
6853-57-2
83-33-0
98-86-2
1 28-37-0
90-43-7
119-47-1
2021-28-5
101-84-8
104-46-1
108-69-0
3717-15-5
5285-87-0
2199-41-9
120-72-9
274-40-3
615-22-5
94-59-7
7140-60-5
2749-59-9
5455-34-5
28338-69-4
604-35-3
633-31-8
601-54-7
570-74-1
InAfl
Sarrdea
44
24
8
4
1
4
1
29
6
1
3
6
^
34
1
2
4
1
1
.1
1
10
6
6
7
3
3
1
1
6
8
3
5
10
1
1
1
5
3
11
1
3
2
8
2.
2
3
33
1
7
39
3
11
4
3
1
1
1
3
1
9
1
1
3
10
In each Age Grcxo
0-14 15-44 45 + '
12
6
0
0
1
2
0
9
1
0
3
1
0
3
0
0
2
0
0
0
0
2
0
1
1
1
2
0
0
1
2
1
1
1
0
0
0
1
1
11
0
0
0
0
0
0
0
4
1
0
10
0
3
0
0
0
0
0
3
0
0
0
1
0
2
15
5
4
0
0
1
0
9
0
0
0
0
0
10
1
0
0
0
1
1
0
3
1
2
2
1
0
0
0
1
0
0
1
2
0
1
0
1
0
0
1
3
1
3
0
0
2
13
0
0
13
1
0
1
1
0
0
0
0
• 0
2
1
0
2
4
17
13
4
4
0
1
1
11
5
1
0
5
1
16
0
2
2
1
0
0
1
5
5
3
4
1
1
1
1
4
6
2
3
7
1
0
1
3
2
0
0
0
1
5
2
2
1
16
0
7
16
2
3
3
2
1
1
1
0
1
7
0
0
1
4
!n Blanks
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0-
0
0
0
21
-------
Table 2 (concluded") • |
Wot
SS
66
67
68
69
70
71
72
73
74
75
76
77
78
79
ao
31
CcmxcndCasj Comooundfa)
(5.Alpha.)-cholest-7-en-3-one
Cholesta-3,5-dien-7-one
(3.Beta.)-cholesta-4,6-dien-3-ol benzoate
Cholesterol
Isomerof cholestenol [5-cho!esten-3-ol propionate]
Pregnans, (S.alpha.)-
(3.Beta.)-26,27-dinorergost-5-en-3-ol benzoate
Chlorinated Hydrocarbon 1,1-Dichtaro-l-prooene
(4-Ch!oropnenyl)phenyl-methanone
2-Chloro-6-methyl-benzonitriie
Dichlorobenzene [1,3-dichloro-benzene]
lindane
ODD
Organo-Silicon Isomer of decamethyl-cydopentasiloxane
Ocamethyl-cyciotetrasiloxane
isomer of decameihyl-cyciopentasiioxane
Phihajao Diheotyl onthalate
Formula (b)
C27.H44.0
C27.H42.0
C34.H48.02
C27.H46.0
C30.H50.02
C21.H36
C33.H48.02
C3.H4.CL2
C13.H9.0.CL
C8.H6.N.CL
C8.H4.CI2
C6.H6.CL6
C14.H10.CL4
C10.H30.05.Si5
C3.H24.04.SI4
C10.H30.05.SI5
C22.H34.04
AS Number (c)
15459-85-5
567-72-6
25485-34-1
57-88-5
633-31-8
641-85-
58003-48-8
563-58-6
134-85-0
6575-09-3
541-73-1
58-89-9
72-54-8
541-02-6
556-67-2
541-02-6
3648-21-3
In All
Sarrdes
1
1
3
3
40
4
1
1
1
1
13
6
12
28
21
1
1
In each Age Group |
0-14
0
0
0
0 •
9
1
0
0
0
1
3
2
4
4
7
0
0
15-44
1
1
2
1
15
0
1
1
1
0
1
0
3
7
3
0
0
45 +
0
0
1
2
, 16
3
0-
0
.0 ':
0.
9.
4
5
17
11
1
1
In Blanks I
• o
0
0
0
0
0
0
0
0
0
0
0
o •'-•
0
"
0
0
(a) Tentative compound identification is based on search vs. the NBS mass spectral library. Confirmation has not been achieved by comparing
retention with an authentic standard. In cases where more than one reference compound successfully matched the unknown spectrum,
a genera) descriptive name is reported and the best ranked NBS name is provided in brackets.
(b) hi cases where both a genera) name and an NBS name is report^, the formula corresponds to the NBS name and may not be applicable to the general name.
(c) In cases Where both a general name and an NBS name is reported, the CAS no. corresponds to the NBS name.
22
-------
Table 3. Compounds Tentatively Identified in the 15/50% Florisil Semivolatile Organic
Analysis Data Set vs. Freauency/Age Group
Index
IS.
1
2
3
4
5
6
7
3
' 9
10
11
12
13
U
15
16
17
18
19
20
21
22
23
24
25
26
27
23
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
CofrncundCass
Internal Standard
Altone
Saturated Ester
Saturated Polyfunctional
Alkene
Unsaturated Aldehyde
Unsaturated Ketona
Unsaturated Polyfuntional
Alkyne
Arena
Aromatic Aldehyde
Aromatic Ketone
Aromatic Amide
Aromatic Carboxylate
Phthalic Acid Derivative
Phenol
Aromatic Polyfunctional
Drug
Heterocydic Compound
Conrcoundfa) . ..:
D10-Anthracene - Internal Standard
Unidentified C10.H20 [Diethyl cyclohexane]
1,7,7-Trimethyl-bicyclo[2.2.1]heptan-2-ol, exo propanoate-
Dodecanoic acid, ethyl ester
Hexanedioic acid,mono(2-ethylhexyl) ester
Alkyl ester [15-Methyl-heptadecanoate]
Ethylhydrazone croDionaidehyde
9-Oxo-nonanoic acid, eihyl ester
1-Methyl-3-{1-methylettienyl)-cyclohexene
. Trimethyl-3-cydohexene-l -carboxaldehyde
2-Butyl-2-octenal
3-Metnyl-3-8uten-2-one, dimer
2,4,6-Cycloheptatnane-1 -one
5-Undecen-4-one
3-Eihyl-2-methyl-4-heptene-3-one
Substituted cyciopentenone (Butyl-methoxy-cyciooenten-1-onej
Substituted cyciopentenone [Butyl-methoxy-cyc!opemen-1-one]
Substituted cyciopentenone [Butyl-methoxy-cyc!openten-1-onej
2-Methoxy-2-octen-4-one
5,5-Dimethyl-3-heptyne
C3-Alkyl benzene [1,3,5-trimethyl-benzene]
C3 Alkyl benzene [1,2,4-Trimethyl-benzene]
C3-Alkyl benzene [1,2,4-trimethyi-benzene]
C3 Alkyl benzene [1-Ethyl-3-methyl-benzene]
Unidentified C11.H10 [1-Ethylidene-indene]
Benzaldehyde
Unidentified C10.H10.0 [.Alpha.-ethylidene-benzeneacetaldehyde]
Unidentified C10.H10.0 [.Alpha.-ethylidene-benzeneacetaldehyde]
1-Phenyl-ethanone
N-Methyl-1 -naphthalenecarboxamida
Benzenepropanoic acid, .beta.,.beta.-dimethyl-
2-{acatylamino)-benzoic adid.methyl ester
Benzenepropanoic acid, ethyl ester
Benzenepropanoic acid
Butyl decyl phthalate
Isomer of diheptyl phthalate
Isomer of diheptyl phthalate
Butyl phthalate, ester with butyl glycolate
Unidentified phthalate
Methyl phenol [2-Methyl-phenol]
(1,1'-Biphenyl]-2-ol
2-Naphthalenol
1 ,3-Dimethoxy-benzene
1-Phenyl-1,2-butanediol
2-Ethoxy-benzaldenyde
Unidentified C7.H5.0.N.S [Thiocyanic acid, 4-hydroxyphenyl ester
Methaquabne
Unidentified barbiturate [5-E!hyl-1,3-dimethyl pyrimidinetrione]
Alkyl substituted pyrimidinetrione [Mephobaroital]
Alkyl substituted pyrimidinetrione [Pentobarbital]
Alkyl substituted pyrimidinetnone [Phenobarbitai]
Alkyl substituted oyrimidinetnone iMetharoital]
Alkyl suosututed pyrimiainetnone {MetnarDitaij
1,7-Naphthyridine
Isomer of dimethyl-piperidine [1,4-Oimethyl-piperidine]
3-Pyridinecarboxaldehyde, oxime
4-Pyridinecarboxaldehyde
Unidentified C8.H7.N [Indolizine]
C2 Alkyl pyrazine [2,6-Oimethyl pyrizine]
2-Methoxy-3-rnethyi-pyrazine
1,2-Benzisothiazole
Unidentified C7.H11.N.S [ 2-MethyU-propyl-thiazole]
Alkyl thazole [4-Ethyl-5-methyl-thiazole]
4-Propyl-thiazole
Number of Occurrences
InAI In each Age Group
Formula(b) CASnumoer(c) Sanples 0-14 15-44 45+ InSanks
C14.D10
C10.H20
C13.H22.02
C14.H28.02
C14.H26.04
C20.H40.02
C5.H1ZN2 .
C11.H20.03
C10.H16
C10.H16.0
C12.H22.0
C5.H8.02
C7.H6.0
C11.H20.0
C10.H18.0
C10.H16.02
C10.H16.02
C10.H16.02
C9.H16.02
C9.H16
C9.H12
C9.H12
C9.H12
C9.H12
C11.H10
C7.H6.0
C10.H10.0
C10.H10.0
C8.H8.0
ciami.o.N
C11.H14.02
C10.H11.03.N
C11.H14.02
C9.H10.02
C22.H34.04
C22.H34.04
C22.H34.04
C18.H24.06
C7.H8.0
C1ZH10.0
C10.H8.0
C8.H10.02
C10.H14.02
C9.H10.02
C7.H5.0.N.S
C16.H14.0.N2
C3.H12.03.N2
C13.H14.03.N2
C11.H18.03.N2
C12.H1Z03.N2
C3.H14.03.N2
C3.H14.03.N2
C3.H6.N2
C7.H15.N
C6.H6.0.N2
C6.H5.0.N
C8.H7.N
C6.H8.N2
C6.H8.0.N2
C7.H5.N.S
C7.H11.N.S
C6.H9.N.S
CS.H9.N.S
1331-43-7
2756-56-1
106-33-2
4337-65-9
57274-46-1
7422-92-6
' 3433-16-7
499-03-6
40702-26-9
13019-1S-4
54789-11-3
539-80-0
56312-55-1
49833-36-7
53690-92-9
53690-92-9
53690-92-9
24985-48-6
23097-98-5
95-63-6
95-63-6
108-67-8
620-14-4
2471-83-2
100-52-7
4411-89-6
4411-89-6
98-86-2
3400-33-7
1010-48-6
2719-60-2
1010-48-6
501-52-0
89-19-0
3648-21-3
3648-21-3
85-70-1
95-48-7
9043-7
135-19-3
151-10-0
22607-13-2
613-69-4
3774-52-5
72-44-6
7391-61-9
115-38-8
76-74-4
50-06-6
50-11-3
30-11-3
253-89-0
695-15-3
51892-18-1
872-85-5
274-40-8
' 108-50-9
2882-21-5
272-16-2
41981-63-9
52414-91-2
41981-60-6
46
2
1
4
1
13
1
2
4
3
28
2
2
3
2
3
4
23
2
1
8
5
1
2
2
8
4
20
4
1
1
2
5
1
11
2
3
6
3
5
18
1
2
2
4
1
4
1
3
19
5
1
3
3
11
10
1
2
3
7
4
3
5
3
12
0
0
0
0
1
1
0
. 1
0
10
2
2
1
1
1
1
6
2
1
4
3
1
0
0
5
2
5
0
0
0
1
1
0
3
1
1
2
0
0
3
0
1
1
2
1
0
0
2
5
3
0
1
0
9
5
1
0
3
3
0
0
3
2
17
0
0
0
0
4
0
0
2
2
9
0
0
0
0
0
0
4
0
0
1
1
0
0
1
1
1
7
2
0
1
0
4
0
4
1
2
1
1
0
6
0
0
0
1
0
4
0
1
8
1
0
1
2
2
4
0
0
0
1
0
0
0
0
17
2
1
4
1
8
0
2
1
1
9
0
0
2
1
2
3
13
0
0
3
1
0
2
1
2
1
3
2
1
0
1
0
1
4
0
0
3
2
5
9
1
1
1
1
0
0
1
0
6
• 1
1
1
i
0
1
0
2
0
3
4
8
2
1
4
3
0
0
1
0
0
0
0
0
0
0
0
0
0
^
i
3
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
4
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
1
0
23
-------
Table 3 (concluded)
Wex
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
Comxxind Class Compound fa)
1,3-Benzcdioxcle
4,7-Dimeihy!-3(2H)"benzofuranone
Unid. C11.H16.02 [Tetrahydro-trirnethyl-2(4H)-benzofuranone]
5-{Butylimino)-2(5H)-furanone
2H-1-8enzopyran-2-one
1 ,3.5-Trimethyl-l H-pyrazole
Isomer of thienyl-ethanone [1-(3-Thienyl)-ethanone]
1-(4-Hydroxy-3-!hienyl)-ethanone
2,3,4-tnmethyl thiophene
2-Methyl-5-propyl-thiophene
2-t-Butoxy-thiophene
Steroid Isomer of cho!est-en-ol [Cholest-S-en-3-oi.acetatej
Isomer of choiest-an-ol [Choiest-S-en-o-ol.acaiatej
Chotest-5-en-3-ol (S.beia.)-, propanoate
Cholest-5-en-3-one
Cho!est-5-ene
Isomer of cholest-en-ol [4-Methyl-cholest-8(14)-en-3-ol]
Cholesta-3,5-dien-7-one
Cho!esta-4,6-
-------
Table 4. Compounds Tentatively Identified in the Volatile Organic Analysis
Data Set vs. Frequency/Census
Index Compound Cass
I.S. Internal Standard
1 Carbon Dioxide
2 Alkane
3
„ 4
5
6
7
8
"* 9
10
11
12
13
14
15
16
17
18
19
20
21 Alkene
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37 Arena
38
39
40
41
42
43
44
45
46
47 Aliphatic Alcohol
48
49
50
51
52
53
54 Unsaturated Alcohol
' 55
56 Aliphatic Aldehyde
57
58
' 59
60
61 Unsaturated Aldehyde
62
63
64
65
66
67
Compound Name (a)
Bromochloropropane - Internal Standard
Carbon dioxide
2-Methyl-butane
Unidentified C5.H10 [Cyclopentane]
C3 Substituted cyclopropane [Propyl-cyclopropane]
C3 Substituted cyclopropane [Propyi-cyclopropane]
2,3-Dimethyl-hexane
1 ,2-Diethyl-cyclobutane
Alkane SC10[Decane]
C10 Alkane [2-Methyl-nonanej
2,2,3,3-Tetramethyl-hexane
Sat alkane 2 C1 1 te-Methyl-c'ecane]
Alkyl substituted hexane jPentyl-cyciohexanej
2,2-Oimethyl-decane
C13 Alkane i3,3-0imethyl-unaecane)
Alkane [6-Eihyl-2-methyl-cecane]
Alkane [2,6,7-Trimethyl-decane]
Alkane 5 C11 [5-{1-Methylprapyl)-nonane]
C13 Alkane [2,2,7-Trimethyl-decane]
3,3,8-Trimethyl-decane
Alkane [6-Methyl-tridecane]
C5 Alkane [1-Pentene]
1-Hexene
Unidentified C6.H12 [1-Hexene]
3-Methyl-1 ,4-heptadiene
1,6-Octadiene
1,3,6-Octatriene
Unidentified C8.H12 [3-Ethylidene-l-methyl-cyclopentenej
1-Nonene
3-Ethyl-2-methyl-1 ,3-hexadiene
C10 Ringed alkane [1,7,7-Trimethyl-bicyclo[Z2.1]hept-2-ene]
1 -Meihyl-4-(1 -methylethenyl)-cyc!ohexene
7-(1-Methylethylidene)-bicyc!o{4.1 .0] heptane
C11 Alkene [1-Undecene]
C11 Alkene [1-Ethenyl-2-hexenyl-cydopropanej
Isomer of Undecen-3-yne [5-Undec-3-yne]
Isomer of Undecen-3-yne [S-Undec-3-yne]
C2 Alkyl benzene {1 ,2-Dimethyl-benzene]
C2 Alkyl benzene [1 ,2-Dimethyi-benzene]
C3 Alkyl benzene [1 ,2,4-Trimethyl-benzene]
C3 Alkyl benzene [1 -Methylethyl-benzene] .
Propyl-benzene
C3 Alkyl benzene [1 -Methyl-2-ethyl benzene]
Isomer of tetramethyl benzene [1,2,3,4-Tetramethyl-benzene]
1-Methyl-3-(1-methylethyl-) benzene
Naphthalene
1 -Ethylpropyl-benzene
3-MethyM-butanol
1-Hexanol
Isomer of ethyl hexanol [3-Methyl-1-hexanol]
2-Eihyl-1-Hexanol
Isomer of octanol [1 -Octanoi]
Isomer of octanol f1 -Octanol]
Unidentified C13.H28.0 [1-Tridecanoi]
Isomer of Octen-ol [3-Octen-2-ol]
Isomer of Octen-ol [3-Octen-2-ol]
Unidentified C5.H10.0 [Pentanal]
Unidentifed C6.H^O [Hexanal]
C7 Aldehyde [Heptanal]
Nonanal
Decanal
2-Methyl-propenal
Isomer of Hexenal [2-Hexenal]
Isomer of Hexenal [2-Hexenal]
C7 Unsat aldehyde [2-Heptenal]
C7 Unsat aldehyde [2-Heptenal]
2,4-Heptadienal
2,4-Nonadienal
Compound
F:ormula(b)
C.02
C5.H12
C5.H10
C6.H12
C8.H12
C3.H18
CS.H16
C10.H22
C10.H22
C10.H22
C11.H24
C11.H22
C12.H26-
C13.H28
C13.H28
C13.H28
C13.H28
C13.H28
C13.H28
C14.H30
C5.H10
C6.H12
C6.H12
C8.H14
C3.H14
C8.H12
C8.H12
C9.H18
C9.H16
C10.H16
C10.H16
C10.H16
C11.H22
C11.H8
C11.H18
C11.H18
C8.H10
C8.H10
C9.H12
C3.H12
C3.H12
C3.H12
C10.H14
C10.H14
C10.H8
CI1.H16
C5.H12.0
O3.H14.0
C7.H16.0
C3.H18.0
C3.H18.0
cam 8.0
C13.H28.O
C8.H16.0
C8.H16.0
CS.H10.0
C8.H1ZO
C7.H14.0
C9.H18.0
C10.H20.0
C4.H6.0
C8.H10.0
ai.H10.0
C7.H12.0
C7.WZO
C7.H10.0
C9.H14.0
Compound
CAS No. (c)
124-38-9
78-784
287-92-3
2415-72-7
2415-72-7
584-94-1
61141-83-1
124-18-5
871-83-0
13475-81-5
3975-98-0
4292-92-6
1 7302-37-3
17312-65-1
82108-21-8
62108-25-2
62185-54-0
62237-99-4
62338-16-3
13287-21-3
109-67-1
592-41-6
592-41-6
1603-01-6
3710-41-6
22038-69-3
62338-00-5
124-11-8
61142-36-7
464-17-5
5989-54-3
53282-47-6
821-954
22822-99-7
74744-31-3
74744-31-3
95-47-6
95-47-6
95-63-6
98-82-8
103-65-1
611-14-3
488-23-3
535-77-3
91-20-3
1196-58-3
123-51-3
111-27-3
13231-81-7
104-76-7
111-37-5
111-87-5
112-70-9
57648-55-2
57648-55-2
110-62-3
66-25-1
111-71-7
124-19-6
112-31-2
78-85-3
6728-26-3
6728-26-3
18829-55-5
57266-86-1
4313-03-5
6750-03-4
Total Number of Occurrences
Number of h Each Region
Occurrences NC N= 5 W
46
45
18
7
13
22
31
3
16
9
10
8
i
'3
1
3
21
1
10
1
4
4
15
24
4
4
10
1
8
44
44
1
1
8
2
17
31
41
16
2
1
8
3
1
2
1
1
29
1
3
7
12
29
1
2
15
46
45
46
46
43
1
21
32
46
23
32
. 2,9
12
11
4
1
5
S
3
0
7
4
2
2
0
a
i
i
4
1
4
1
3
0
4
7
2
2
4
0
2
10
11
1
0
1
0
6
8
12
8
0
1
2
1
0
2
0
1
11
1
0
3
3
5
1
0
7
12
12
12
12
11
0
3
6
12
7
9
7
9
9
5
1
1
5
7
0
2
3
4
0
0
1
0
3
3
0
0
0
0
0
2
5
0
1
3
0
2
9
8
0
0
0
0
2
7
9
1
0
0
0
0
0
0
0
0
5
0
1
1
*
a
0
0
2
9
9
9
9
9
0
5
9
9
4
8
9
19
19
6
4
7
11
13
3
7
0
3
4
0
5
0
2
13
0
6
0
1
4
5
fl
1
0
1
0
4
19
19
0
0
4
1
6
12
17
7
2
0
6
2
1
0
1
0
10
0
H
2
7
10
0
2
5
19
18
19
19
18
1
10
13
19
8
12
10
6
6
3
1
0
0
3
0
0
2
1
0
1
1
0
2
1
0
0
0
0
0
4
1
1
1
2
1
0
6
6
0
1
3
1
3
4
3
0
0
0
0
0
0
0
0
0
3
0
1
1
•i
5
0
0
1
6
6
6
6
5
0
3
4
6
4
3
3
25
-------
VxfeX CorrpcundChss
68
69
70
71
72
73
74
75
76 Aliphatic Kefona
77
• f
78
79
30
31 Unsaiurated Keiona
32
33
84
85 Aliphatic Ether
86 Aliphatic Ester
87
88
89
90
91
92
93
94
95
96
97
«* f
98
99
100
102
103
104
105
106
107
108
109
110
111 Unsaturatod Ester
112 HaJocaiton
114
115
116
117 Phenol
118 Hotarccyda
<19 Suifida
190
[6w
121 Organo-Siltcon
I au i c; -r ^i-ui
Compound Mams (a)
Isomer of decenal [2-Decenai]
Isomer of decenal [2-Decenai]
UnsaL aldehyde [2-Decenai]
UnsaL aldehyde [2-Oecenaij
UnsaL aldehyde [2-Decenal]
Diene aldehyde [2,4-Oecaaienal]
Oiene aldehyde (2,4-0 ecaflienaij
Diene aldehyde [2,4-Oodecadienal]
07 Ketone [2-Heptanone]
4-Heptanone
Unidentified C7.H12.0 [2,Z3-Trimethyl-cyclobutanone]
08 Ketone [3-Octanonej
SaL ketone [2-Oecanone]
isomer of Oc:en-one [3-Octen-2-one]
03 Ketone [3-Octen-f-one]
3,5-Octadien-2-one
09 UnsaL ketone [3-Nonen-2-one]
Dimethoxy methane
Propanoic acid, ethyl ester
05 Methyl ester [Butanoic add, methyl ester]
Propanoic add, propyl ester
Pontanofcadd, methyl ester
07 Methyl ester [Hexanoic add, methyl ester]
3-Methyl butanoic add, ethyl ester
Propanoic add, butyl ester
2-Methyl prapanoic add, 1-methylethyl ester
Acetic add, pentyl ester
2-Methyl butanoic acid, ethyl ester
08 Ethyl ester [Hexanoic acid, ethyl ester]
Acetic add, hexyl ester
08 Ester [3-Methyl butanoic add, propyl ester]
08 Ester [Bulanoic acid, 1-Methylpropyl ester]
08 Ester [Butanoic acid, 1-Methylpropyl ester]
Octanoic add, methyl ester
Hexanoic add, 1-melhy!ethyl ester
Butanoic acid, pentyl ester
Hexanoic add, 2-methylprapyl ester
Octanoic add, ethyl ester
010 Ester [2-Methyl-propanoic acid, hexyl ester]
011 Ester [Hexanoic add, pentyl ester]
011 Ester [4-Methyl pentanoic acid, pentyl ester]
011 Ester [Hexanoic acid, 2-Methylbutyl ester]
Isomer of octanoic acid [3-Methyl-butyl ester]
3-Octen-1-ol, acetate
05 Bromoalkane [1-Bromopentane]
3-Bromo-Pentane
Brominated alkane 5 07 [1-Bromo-heptane]
Dichlorobutane [1,4-dichlorobutane]
2-8romo-2-chloro-1 ,1 .trifluoro-ethane
Isomer of ethyl-phenol [4-Ethyl-phenol]
Unidentified C3.H14.0 [2-Pentyl-furan]
Dimethyl disulfide
Dimethyl tnsuifide
Decamethyl-cydopentasiioxane
Conpcund
Formula (b)
C10.H18.0
C10.H18.0
C10.H18.0
C10.H18.0
C10.H18.0
C10.H16.0
C10.H16.0
C12.H20.0 •
C7.H14.0
C7.H14.0
C7.H1ZO
cam 6.0
C10.H20.0
C3.H14.0
C3.H14.0
C3.H1ZO
C9.H16.0
C3.H8.02
C5.H10.02
C5.H10.02
C6.H1Z02
C8.H12.02
C7.H14.02
C7.H14.02
C7.H14.02
C7.H14.02
C7.H14.02
C7.H14.02
C8.H16.02
cam 6.02
C8.H16.02
C3.H16.02
cam 6.02
C9.H18.02
C9.H18.02
C9.H18.02
C10.H20.02
C10.H20.02
C10.H20.02
C11.H22.02
C11.H22.02
C11.H22.O2
C13.H26.02
C10.H18.02
C5.H11.BR
C5.H11.BR
C7.H15.BR
C4.H8.CL2
CZH.CLBR.F3
C8.H10.0
C9.H14.0
CZH6.S2
C2.H6.33
C10.H30.05.SI5
Total
Compound Number of
CAS No. (c) OccuiTCJices
3913-81-3
3913-81-3
3913-81-3
3913-81-3
3913-81-3
25152-84-5
25152-84-5
21662-16-8
110-43-0
123-19-3
1449-49-6
106-68-3
693-54-9
1669-44-9
1669-44-9
30086-02-3
14309-57-0
109-87-5
105-37-3
623-42-7
106-36-5
624-24-8
106-70-7
108-64-5
590-01-2
617-50-5
628-63-7
7452-79-1
123-66-0
142-92-7
557-00-6
819-97-6
819-97-6
111-11-5
2311-46-8
540-18-1
105-79-3
106-32-1
2349-07-7
540-07-8
25415-71-8
2601-13-0
2035-99-6
69668-83-3
110-53-2
1809-10-5
629-04-9
110-56-5
151-67-7
123-07-9
3777-69-3
324-92-0
3658-80-8
541-02-6
1
25
28
29
45
1
15
26
36
35
7
1
1
9
37
8
25
1
29
3
7
1
42
16
2
4
3
5
12
16
7
1
4
27
1
17
1
36
12
24
6
4
24
1
3
3
2
2
16
6
29
27
2
28
Number of Occurrences
h Each Region
NO N= S W
0
8
4
6
12
0
' -1
8
, 10
• 12
2
1
1
11
2
5
11
1
. 4
1
10
10
1
2
1
2
3
4
4
1
2
7
0
4
0
12
5
5
3
3
6
1
1
1
1
7
8
11
2
7
0
6
4
7
9
0
4
5
6
8
2
0
2
0
7
4
1
4
0
0
0
8
0
0
0
1
0
3
1
0
0
8
3
0
8
2
7
0
0
4
0
0
0
0
1
4
1
8
1
0
2
1
7
14
12
18
6
Tt
15
11
2
0
6
13
6
9
12
1
2
0
18
5
1
2
1
3
4-
9
3
2
8
7
1
11
4
10
2
1
9
0
1
0
1
4
1
5
9
13
0
14
0
4
6
4
6
4
2
5
4
1
0
0
0
4
2
1
1
0
6
1
0
0
0
0
2
2
0
0
4
3
0
5
1
2
1
0
5
0
1
2
0
3
•J
)
4
2
0
5
(a) Toniamm compound identification is based on search vs. the NBS mass spectral library. Confirmation has riot been achieved by comparing
retsnlionwthanauthenlicstandard. In cases where more than one reference compound successfully matched the unknown spectrum,
a general descriptive name is reported and the best ranked NBS name is provided in brackets.
(b) In cases where both a general name and an NBS name is reported, the formula corresponds to the NBS name and may not be applicable to the general name.
{c) In cases where both a general name and an NBS name is reported, the CAS no. corresponds to the NBS name. .
26
-------
Table 5. Compounds Tentatively Identified in. the 6% Florisil Semivolatile Organic
Analysis Data Set vs. Frequency/Census Region
Index
I.S
1
2
3
-4
5
5
7
.8
9
10
11
12
'.3
14
15
16
17
18
1?
20
> 21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
-52
53
"54
55
56
57
*58
59
60
61
62
Comoound Class
Internal Standard
Alkane
Saturated Ketone
Saturated Ester
Sutfide
Oipeptida
Akene
Unsatuiated Aldehyde
Unsaturated Amine
Unsaturated Ketona
Arena
Aromatic Aldehyde
Aromatic Ketone
Phenol
Aromatic Esier
Aromatic Ether
Aromatic Amine
Aromatic Oxime
Thiocyanic Ester
Heterocyclic Compound
Steroid
Compound Name (a) J-'
D10- Anthracene
2,6,1 0,14-Tetramethyl-hexadecane
2,6,1 0,1 4-Tetramethyl-nonadecane
Alkane 2 C18 [2,6,10,14,19-Pentamethyl eicosane)
1,2,4-Cyciopentatrione
12-Methyl-tridecanoic acid, methyl ester
Nonanedioic acid. bis(1 -methylpropyl) ester
9-Octadecenoic acid, ethyl ester
Methyl 2-methyM-{methylthio)buiyl disuifide
Dimethyl trisullida
Giycine, anhydride
C5 Substituted naonthaiene
iOctahydro-teirametnyl-IH-cycioorooaniAlnaDmhalenel
Hexahydro-4,7-dimetnyt-1-(1-m8triyiethvi)-naDnthaiene...
5-cthyiidene-1 -methyl-cycioheptene
C30 Unsat. hydrocarbon (Hexametnyl-tatracosanexaene)
Ylangene
2-8utyl-2-octenal
Unidentified C9.H8.0 [Cyclooctatetraene-l-carboxaHehydej
N,N-Dimethyl-3-octen-2-amine
6,10-Oimethyl-5,9-undecadien-2-one
C4 Alky! benzene [1-Ethyl-2,3-dimethyl benzene)
2-Ethyl-1 ,3-dimethyl-benzene
C4 Alkyl benzene [4-Ethyl-1,2-
-------
Table 5 (concluded)
hta
63
84
65
66
67
33
39
70
71
72
73
r*
:»s
?6
77
78
79
ao
31
Compound Casa Compound Nama (a)
Chotast-5-an-3-on9
Cho!est-5-ene
(5.A|pna.}-cholest-7-en-3-one
Cholesta-3,5-olan-7-ona
(3.E«ta.)-cho!esta-4,6-d:en-3-ol benzoata
Cholesterol
Esomerolcholestanol [S-chotesten-3-ol propionatej
Pregnane. (5,alpha,)-
(3.Beta.}-26.27-dinorsrgost-5-en-3-ol benzoate
CHonratftd Hydrocarbons 1,1-0icn!ora-1-propena
(4-Ch!orephenyl]phenyl-methanon8
2-Chloro-6-methyl-benzonitnle
Oiehbrcbenzene [1.3-dichlorc-ienzene|
Undana
ODD
OfB3flC-S3con fsomer of decamethyl-cyciopemasitoxane
Cctameihyl-cyclojeirasiloxana
isomar of decamethyl-cyclopentasiloxana
Phthalaw Oiheptyl pnthatata
Compound
Formula (b)
C27.H44.0
C27.H46
C27.H44.0
C27.H42.0
C34.H48.02
C27.H46.0
C30.H50.02
C21.H36
C33.H48.02
C3.H4.CL2
C13.H9.0.CL
C3.H6.N.CL
CS.H4.CI2
Co.H6.CL5
C14.H10.CL4
C10.H30.05.SI5
C8.H24.04.SI4
C10.H30.05.SI5
C22.H34.04
Compound
CAS Number (c)
601-54-7
570-74-1
15459-85-5
567-72-6
25485-34-1
57-88-5
633-31-3
641-85-
58003-48-8
563-53-6
134-85-0
5575-09-3
541-73-1
58-39-9
72-54-8
541-02-6
556-67-2
541-02-6
3648-21-3
Total Number
of Occurrences
Samples Blanks
3
10
1
1
3
3
40
4
1
1
1
1
13
5
12
28
21
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Number of Occurrences
in Each Region
NC NE 3 W
0
4
0
0
0
0
12
0
0
1
0
1
4
2
3
7
3
0
0
0
1
0
0
0
1
9
2
0
0
0
0
2
3
1
5
5
0
0
2
4
1
1
2
1
16
1
1
0
0
0
8
t
3
12
9
0
0
1
1
0
0
1
1
3
1
0
0
1
0
1
0
0
4
4
1
1
(a) T««»l.V» compound idonuHtaiion is based on search vs. the NBS mass spectral Ibrary. Confirmation has not been achieved by comparing
raUffiJMl with an auhentic standard. In cases where more than one reference compound successfully matched the unknown spectrum,
a otntral tfescnplrva nama 'a reported and the best ranked NBS nama is provided in brackets.
0} En casts vrtvon both a general nama and an NBS name is reported, the formula corresponds to the NBS name and may not be applicable to the general name.
(c) In easts vrtwra both a General name and an NBS name is reported, the CAS no. corresponds to the NBS name.
28
-------
Table 6. Compounds Tentatively Identified in the 15/50% Florisil Semivol
Analysis Data Set vs. Freauencv/Census Reaion
Index
ia
1
2
3
4
5
5
7
8
9
10
11
!2
13
!4
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
33
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57 '
58
59
SO
61
62
63
Com pound Class
Internal Standard
Alkane
Saturated Ester
Saturated Polyfunasonal
Atone
Unsaturated Aldehyde
Unsaturated Ketone
Unsaturated Polyfuraional
Alkyna
Arena
Aromatic Aldehyde
Aromatic Ketone
Aromatic Amide
Aromatic Carboxylata Derivative
Phthalic Acid Derivative
Phenol
Aromatic Polyfunctional
Drug
Heterocydic Compound
Compound Nama (a)
010-Anthracene - Internal Standard
Unidentified C10.H20 [Diethyl cyciohexana]
1,7,7-Trim8thyl-bicyclo[2.2.1]haptan-2-ol, exo propanoate-
Dodecanoic acid, ethyl estar
Hexanedioicacid,mono(2-ethyihexyl) ester
Alkyl ester [15-Methyl-heptadecarioate|
Elhyihydrazona propionakiehyda
9-Oxc-nonanoic acid, athyl ester
1 -MethyK5-(1 -melhylethenyl)-cyclohexene
Trimethyl-3-cyclohexene-l -caAoxaWehyda
2-Sutyl-2-octanal
3-Methyl-3-8ut8n-2-on8, dimer
2,4,6-Cycioheptatnene-t -one
5-Unaecen-4-one
5-cthy(-2-memyl-4-ri8pten8-3-on8
Substituted cyclopentenone [3utyl-metnoxy-cyck3pantan-1-one|
Substituted cydopentenone [Butyl-methoxy-cyciopeman-l-onal
Subsdtuted cyctopantenone [Butyl-methoxy-cyclopenten-1-one|
2-Methoxy-2-octen-4-ona
5,5-Dimathyl-3-h8ptyn8
C3-Alkyl banzene [1 ,3,5-trimethyl-benzenel
C3 Alkyl benzene [1,2,4-Trimethyl-benzenej
C3-Alkyl benzene (1,2.4-trimethyl-benzenej
C3 A8
-------
6 (concluded)
hfcx ComcoundCaj
64
65
66
87
68
69
70
?t
n
73
74
75 Strcid
;B
77
78
79
30
31
32
33
34
85
36
87
88
89
90 BaJoQOnaiKJ Hydrocarbon
31
92
93
94
95 Organo-StHcon
96
ComDound Name (a]
1.3-Benzodioxcle
4,7-Dimathyl-3(2H)-benzofuranon9
Unidentified C11.H16.02 [Tetrahydro-tri[T!ethyl-2(4H)-benzoluranone]
5-{8utylimino)-2(5H)4uranone
2H-1-Benzopyran-2-one
1,3,5-TrimethvHH-cyrazole
isonw of Ihtenyt-ethanona (1-(3-Tnienyl)-ethanone|
V{4-Hydroxy-3-thienyl)-«thanone
2,3,4-trimeihyl ihtophane
2-Meihyl-5-propyl-tniophene
2-t-Butoxy-lhiophen9
Isomer of cho!est-en-ol (Cholest-5-an-3-ol,acetate|
isomer of cnolest-en-ol IChoisst-5-en-3-ol,acetai8J
Cho!esi-5-en-3-ol (3.beta.)-, propanoate
Chotest-5-en-3-one
Cholest-S-ena
Isomsr of cholest-en-ol [4-Methykholest-8(14)-en-3-oll
Chc!esta-3,5-dien-7-one
Chotesta-4,6-dien-3-ol (S.Beta.). Banzoate
Cho!8sta-5.7-dien-3-ol, (S.beta.)
Isomer of choiestanol [Cholestanol]
Methyl-cho!estan-3-ol, (3.beta.,5.aipha.,6.b8!a.)-
3-(Aco!oxy)-chol9sian-6-on9. (3.beta,5.alpha.)-
Chotesian9-3,5-diol, (3.beta..5.alpha.)-
Cholestanol
Cholesterol
1-Ch!oro-4-{Methy!sulfonvl)-benzene
Iscmerof ftuoro-methyl-benzene [l-Fkioro-2-methyl-benzenel
Carbonochforidothioic acid, S-methyl ester
1,1-OicMorc-ethene
4-Chloro-2-(p he nylmeihyl) -phenol
1-ButynyUrimethyl si!ane
Trim8thyt({1-m8ihyl-2-propynyl)oxyj-siian9
Compound Compound
Formula (b) 3AS Numbsr (c)
C7.H6.02
C10.H10.02
C11.H16.02
C8.H11.02.N
C9.H6.02
CS.H10.N2
C3.H6.0.S
C6.H6.02.S
C7.H10.S
C8.H12.S
C8.H12.0.S
C29.H48.02
C29.H48.C2
C30.HS0.02
C27..H44.Q
C27.H46
C28.H48.0
C27.H42.0
C34.H48.02
C27.H44.0
C27.H48.0
C28.H50.0
C29.H48.03
C27.H48.02
C27.H48.0
C27.H46.0
C7.H7.02.S.CL
C7.H7.F
C2.H3.0.S.CL
C2.H2.CL2
C13.H11.0.CL
C7.H14.SI
C7.H14.0.SI
274-09-9
20895-45-8
17092-92-1
27396-39-0
91-64-5
1072-91-9
1468-83-3
5556-16-1
1795-04-6
33933-73-2
23290-55-3
504-35-3
604-35-3
504-35-3
501-54-7
570-74-1
52014-96-4
567-72-6
633-31-8
434-16-2
80-97-7
43217-65-8
1256-83-3
3347-60-2
80-97-7
57-88-5
98-57-7
95-52-3
2812-72-8
75-35-4
120-32-1
62108-37-6
1 7869-76-0
Total Number
of Occurrences
Samcles Blanks
2
4
6
3
1
1
7
3
5
4
4
37
25
45
44
30
5
22
45
3
23
15
3
2
4
44
1
10
5
1
4
7
5
0
0
0
0
0
1
0
0
0
0
0
1
0
2
2
0
0
1
2
0
0
0
0
0
0
1
0
1
0
0
0
0
0
Number of Occurrences
intacriRscpon
NC HE S W
1
2
, 3
0
0
0
2
0
4
1
1
: 9
1 7
12
12
10
3
5
12
2
9
5
0
1
1
11
1
3
1
0
0
2
2
1
0
0
3
1
0
2
0
0
0
0
7
3
9
a
4
1
4
9
1
3
3
0
0
0
9
0
3
1
0
3
1
0
0
2
2
0
0
1
2
1
1
3
2
16
9
19
19
14
1
11
19
0
11
6
1
1
2
19
0
3
0
0
1
3
3
0
0
1
0
0
0
1
2
0
0
1
5
1
5
5
2
0
2
5
0
0
1
2
0
1
5
0
1
3
1
0
1
0
(a) Tentatrva compound idertilicatjon is based on search vs. the NBS mass spectral Ifcrary. Confirmation has not been achieved by comparing
faiantion with an au*o«ic standard \n cases where more than one reference compound successfully matched the unknown spectrum,
a csr.oral dascnptivo tuma is reported and the best ranked NBS name is provided in bracken.
(b} !fl CiSM whars both a cenoral nams and an NBS name is reported, the formula corresponds to the NBS name and may not be applicable to the general name.
(cj hcaswwrars both a general name and an NBS name is reported, the CAS no. corresponds to the NBS name.
30
-------
Table 7. Unidentified Peaks in the Volatile Organic Analysis Data
Set vs. Frequency/Census Region
Index
I.S.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33 .
34
35
36
37
38
39
40
41
42
43
44
45
46
Average
RRT
1.000
.481
3.216
3.114
2.659
4.213
.370
2.398
.405
2.890
4.353
3.862
.286
3.322
3.314
2.771
2.689
1.997
3.384
3.873
2.666
4.390
2.570
3.962
' 4.142
.335
2.369
2.619
3.364
3.812
1.488
2.572
3.177
4.159
2.053
.4.388
4.573
.802
1.744
2.495
2.867
2.906
. 3.308
3.501
4.319
.277
.408
Total
Number of
Occurrences
46
46
46
45
44
43
41
41
34
30
28
24
23
21
18
14
13
12
12
12
11
11
10
9
9
8
8
8
8
8
7
7
7
7
6
6
6
5
5
5
5
5
5
5
5
4
4
North Central
12
12
12
11
12
11
9
11
11
8
4
6
5
10
7
4
5
2
3
1
3
2
2
0 •
4
1
1
2
1
2
1
4
2
1
3
1
3
1
0
2
2
1
4
0
2
2
0
Number of Occurrences
in Each Region
Northeast South
9
9
9
9
9
9
9
8
8
6
9
6
3
4
4
2
1
6
0
2
1
2
1
1
0
1
2
2
4
4
0
0
3
0
2
2
3
4
2
1
2
1
0
0
1
1
0
19
19
19
19
18
17
18
18
12
11
10
12
12
5
6
7
5
3
9
7
6
4
5
7
5
6
4
3
3
1
6
2
2
4
1
3
0
0
1
2
0
2
0
5
2
1
2
West
6
6
6
6
5
6
5
4
3
5
5
0
3
2
1
1
2
1
0
2
1
3
2
1
0
0
1
1
o
1
0
1
o
2
o
o
0
0
2
0
1
1 •
1
0
o
o
2
31
-------
Table 7 (conti
Index
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
Average
RRT
1.719
3.064
3.159
3.513
3.881
3.908
4.317
.381
1.141
2.721
3.482
4.146
.285
.573
2.141
2.892
3.012
3.551
3.564
3.700
3.963
4.113
.313
1.036
1511
1.672
2.028
2.239
2.262
2.271
2.301
2.407
2.671
2.891
2.907
2.988
3.073
3.100
3.175
3.314
3.371
3.453
3.461
3.494
3.650
3.782
3.829
Total
Number of
Occurrences
4
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
'1
1
1
1
1
1
1
1
1
1
1
1
!
1
1
1
North Central
1
0
2
3
2
0
0
2
2
2
1
2
2
1
2
0
1
0
2
1
0
0
1
1
0
1
0
1
0
0
1
1
0
0
0
1
0
0
0
0
0
1
1
1
0
0
1
nued)
Number of Occurrences
in Each Region
Northeast South
0
0
0
1
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0 •
0
1
0
2
2
2
0
1
1
3
1
0
0
1
1
0
0
0
2
0
1
0
1
0
2
0
0
0
0
0
0
1
1
0
0
0
0
0
0
1
1
1
1
1
0
0
0
1
0
0
West
1
2
0
0
1
0
1
0
1
• 1
1
0
0
1
0
0
1
1
0
0
, 1
0
0
0
1
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
32
-------
Table 7 (concluded)
Index
94
95
96
97
98
99
Average
RRT
3.975
3.993
4.192
4.635
4.812
5.004
Total
Number of
Occurrences
1
1
1
1
1
1
Number of Occurrences
In Each Region
North Central
0
0
0
0
0
0
Northeast
0
0
1
1
1
1
South
1
1
0
0
0
0
West
0
0
0
0
0
0
33
-------
Table 8.
Index Average RRT
IS
1
2
3
4
5
6
7
E
g
1C
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
28
27
28
29
30
31
32
33
34
35
36
37
38
3S
40
41
42
43
44
45
46
47
48
49
50
1.000
0.924
1.600
0.759
1.027
1.023
1.117
1.706
1.129
0.879
0.702
0.919
0.990
0.838
0.912
1.481
1.760
0.985
1.059
0.673
0.993
0.982
1.533
1.063
1.199
1.374
0.726
1.741
0.952
1.237
1.629
1.586
0.493
1.002
1.065
0.839
1.070
1.728
0.574
0.665
1.178
1.280
1.297
0.190
0.666
0.310
0.603
1.082
1.131
1.146
0.411
Unidentified Peaks in the 6% Florisil Semivolatile Organi
Analysis Data Set vs. Frequency/Census Region
Total Number of Occurrences in Each
Number of
Occurences North Central Northeast
44
42
42
38
38
35
34
34
32
31
30
30
29
28
26
26
25
24
24
23
23
22
22
21
21
21
19
19
17
17
17
16
15
15
15
14
14
14
13
13
13
13
13
12
12
11
11
11
11
11
10
12
12
12
10
12
9
12
11
12
10
9
9
9
8
6
9
7
7
8
6
5
8
8
6
9
6
7
6
7
6
3
6
3
5
4
3
4
6
2
6
5
5
4
3
5
4
1
3
2
3
3
9
9
7
9
8
6
3
5
1
6
4
7
4
4
5
1
2
5
1
6
6
3
2
4
3
3
3
3
2
1
2
1
5
2
2
3
1
1
0
2
0
1
0
3
4
2
1
0
3
2
1
Region
South
18
18
18
17
13
16
15
16
15
14
13
12
13
13
11
14
14
10
12
8
10
9
11
8
9
11
8
9
6
7
11
9
4
7
8
7
6
6
9
5
7
6
8
4
2
2
8
5
4
3
3
West
5
3
5
2
5
4
4
2
4
1 '
4
2,
3
3
4
2
2
2
3
3
2
2
1
3
0
1
1
1
2
3
1
0
3
1
1
1
3
1
2
0
1
1
1
2
1
3
1
3
2
3
3
C
Number of
Occurences in
Blanks
3
0
2
0
0
0
0
1
0
0
0
0
0
0
0
2
1
0 *
0
0
0
0
1
0
0
1
0
0
0
0
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34
-------
Table 8 (continued)
Index Average RRT
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
0.780
1.009
1.160
1.219
1.224
0.220
0.670
0.959
1.178
1.197
1.626
1.638
0.360
0.674
0.897
0.932
1.051
1.094
1.427
1.475
1.681
1.773
0.337
0.662
0.880
1.177
1.253
1.681
0.278
0.472
0.736
0.991
1.057
1.069
1.073
1.085
1.195
1.407
0.399
0.661
0.730
0.965
1.068
1.144
1.195
1.222
1.326
1.355
1.389
1.411
1.538
Total
Number of
Occurences
10
10
10
10
9
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
• 4
4 •
Number of Occurrences in Each
North Central Northeast
2
2
4
4
4
2
0
4
2
0
3
4
2
1
1
2
3
4
1
1
4
2
1
1
1
4
3
1
0
2
2
3
3
2
1
2
0
3
0
3
1
0
2
2
2
1
1
2
2
.2
1
1
0
2
2
2
3
1
1
1
1
1
0
0
4
0
2
1
1
1
5
1
2
0
2
1
0
0
1
3
0
0
0
0
2
2
2
0
0
4
0
0
3
0
1
0
0
1
0
0
0
1
Region
South
5
5
3
3
1
1
6
2
4
5
4
4
4
2
6
3
1
2
4
1
1
3
4
1
2
2
2
4
2
3
3
2
1
1
1
1
3
2
0
1
2
1
1
1
1
2
0
2
2
2
1
West
2
3
1
1
2
2
1
1
1
2
0
0
1
0
0
0
2
0
1
0
1
0
1
2
2
0
1
0
0
0
0
0
1
0
1
0
. 2
0
0
0
1
0
1
0
1
1
2
0
0
0
1
Number of
Occurences in
Blanks
0
0
0
0
o
0
o
0
o
0
o
0
o
0
o
0
o
o
1
o
o
o
o
o
o
o
o
2
o
o
o
o
o
o
o
o
o
o
o
o
o
2
o
o
o
o
o
o
o
o
0
35
-------
Table 8 (continued)
Index Average RRT
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
14S
144
145
146
147
148
149
150
151
152
0.316
0.608
0.662
0.747
0.754
0.855
0.893
0.918
0.967
1.01S
1.025
1.041
1.045
1.050
1.055
1.076
1.107
1.109
1.186
1.244
1.251
1.414
1.457
1.585
0.325
0.356
0.747
0.754
0.817
0.823
0.855
0.896
0.898
0.905
0.933
0.976
0.982
0.985
1.020
1.038
1.053
1.080
1.105
1.120
1.124
1.143
1.152
1.158
1.179
1.221
1.252
Total
Number of
Occurences
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Number of Occurrences in Each
North Central Northeast
1
1
0
0
3
0
0
1
3
1
0
1
1
0
2
3
0
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
2
0
2
1
0
1
0
0
1
2
0
0
0
0
0
1
0
0
2
0
0
0
0
0
2
1
2
0
1
0
0
3
0
1
0
0
1
0
0
0
2
2
0
0
2
0
1
2
2
0
0
0
0
0
0
0
c
1
2
0
0
0
1
1
0
0
Region
South
0
1
2
0
0
1
3
2
0
0
2
0
2
1
1
0
0
3
1
3
2
1
3
3
1
0
0
2
0
0
1
0
0
0
1
2
0
1
0
1
2
1
0
0
1
0
1
1
0
2
2
West
1
1
1
1
0
2
0
0
0
0,
0,
0
0
1
0
0
0
0
1
0
0
1
0
0
0
0
0
0
1
0
1
1
0
0
1
0
0
1
0
0
0'
0
1
0
0
0
1
0
1
0
0
Number of
Occurences in
Blanks
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Q
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36
-------
Table 8 (continued)
Index Average RRT
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
, 195
196
197
198
199 '
200
201
202
203
1.336
1.345
1.360
1.382
1.542
1.577
1.589
1.600
1.680
1.727
1.731
0.229
0.255
0.266
0.269
0.279
0.293
0.300
0.329
0.357
0.406
0.406
0.463
0.499
0.539
0.575
0.672
0.676
0.708
0.724
0.732
0.732
0.734
0.742
0.743
0.747
0.749
0.799
0.829
0.830
0.855
0.892
0.911
0.914
0.973
1.011
1.018
1.035
1.051
1.053
1.060
Total
Number of
Occurences
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Number of Occurrences in Each
North Central Northeast
2
0
1
1
0
2
0
0
0
1
1
0
0
0
0
0
1
0
1
0
1
1
0
0
0
0
0
0
0
1
1
0
0
0
0
0
1
1
0
1
1
0
0
1
1
1
0
0
0
0
0
0
0
1
0
0
0
1
1
0
1
0
1
1
1
0
0
0
1
0
0
0
0
1
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
1
1
0
0
0
0
0
0
1
0
Region
South
0
2
0
1
2
0
1
0
2
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
1
1
0
0
o
o
1
1
1
d
0
0
0
0
0
0
o
0
0
1
1
1
0
1
West
0
0
o
o
0
0
o
1
o
o
o
o
0
o
1
1
o
0
o
1
o
o
o
o
1
o
o
o
o
o
o
1
o
o
o
o
o
o
o
o
o
o
o
o
0
o
o
o
o
o
0
Number of
Occurences In
Blanks
0
o
o
n
•J
o
o
o
u
o
o
1
t
o
\J
o
o
n
V
0
V
o
u
o
o
o
u
n
u
o
n
\J
o
n
V
o
V
n
V
n
V
n
\j
n
\J
n
\J
n
V
n
V
n
V
n
u
A
\J
n
U
n
U
n
\J
2
Cm
o
n
\J
n
U
n
V
n
U
n
V
0
37
-------
Table 8 (continued)
Index Average RRT
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
1.064
1.075
1.078
1.084
1.107
1.117
1.117
1.118
1.121
1.122
1.134
1.134
1.138
1.140
1.140
1.152
1.161
1.170
1.189
1.208
1217
1.226
1.262
1.288
1.289
1.304
1.348
1.349
1.349
1.350
1.356
1.375
1.379
1.394
1.407
1.534
1.588
1.590
1.596
1.624
1.634
1.646
1.659
1.676
1.678
1.701
1.709
1.718
1.721
1.731
1.734
Total
Number of
Occurences
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Number of Occurrences in Each
North Central Northeast
0
1
0
1
0
0
0
0
0
0
0
0
1
0
0
1
0
1
0
0
1
0
0
1
0
0
0
0
1
1
1
1
0
1
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
1
0
0
1
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
1
0
0
1
0
0
1
Region
South
0
0
0
0
1
0
1
1
1
1
0
0
0
1
1
0
0
0
1
0
0
0
1
0
1
0
1
1
0
0
0
0
1
0
1
1
1
0
1
0
1
1 •
1
0
0
1
1
0
1
1
0
West
0
0
1
0
0
0
0
0
0
0 •
1 .
0
0
0
0
0
0
0
0 '
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
o ,
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Number of
Occurences in
Blanks
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
• o
38
-------
Table 8 (concluded)
Index
255
256
257
, 258
Average RRT
1.734
1.740
1.804
1.889
Total
Number of
Occurences
1
1
1
1
Number of Occurrences in Each Region
North Central
0
0
1
0
Northeast
1
0
0
0
South
0
1
0
1
West
0
0
0
0
Number of
Occurences in
Blanks
0
o
o
0
39
-------
Table 9. Unidentified Peaks in the'15/50% Florisil Semivolatile
Organic Analysis Data Set vs. Frequency/Census Region
Index
IS.
1
2
3
4
5
6
7
8
9
10
1:
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
33
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
58
57
58
59
60
61
62
63
Averags Total Number
RRT of Occurrences
1.000
1.920
0.419
1.052
1.007
0.452
1.616
0.402
0.633
1.742
0449
1569
2.034
1.692
1.682
1.710
0.437
0.606
1.238
1.657
1.187
1.453
0.839
1.665
0.647
1.128
2.059
1.953
1.440
1.490
1.722
1.430
0.932
1.115
1.223
2.009
0.589
1.147
1.557
1.235
1.178
0.555
0.990
1519
1.629
0.876
0.680
0.912
1.086
1.089
1.556
1.980
1.929
0.982
1.809
1.027
1510
1500
1.950
0.586
0.858
1511
1561
2.014
46
44
42
41
40
38
38
37
35 •
35
34
34
Zt-
33
32
32
29
29
29
28
28
28
27
27
26
26
26
25
25
24
23
22
21
21
21
20
20
20
20
19
18
18
17
17
16
16
15
15
15
15
15
15
14
14
14
13
13
13
13
12
12
12
12
12
Number of Occurrences in Each Region
North Central Northeast South
12
12
11
12
12
11
12
10
9
11
10
10
10
11
10
11
6
7
12
10
9
11
10
10
7
11
9
6
8
8
8
7
7
8
6
6
5
5
6
6
5
2
7
6
5
4
3
6
5
6
5
4
3
6
3
6
5
4
4
4
5
4
5
4
9
9
9
6
5
6
6
7
9
6
6
5
5
4
7
3
7
6
2
6
3
4
3
3
4
0
2
4
3
3
4
3
1
0
3
2
5
0
3
1
3
6
1
2
3
2
2
0
1
2
3
2
1
1
2
0
3
3
2
0
3
3
1
0
19
18
17
18
18
15
17
14
13
16
12
16
14
16
14
16
10
11
13
10
14
11
12
13
12
14
13
13
13
11
9
11
12
11
9
10
5
13
9
11
9
8
9
8
7
8
7
8
6
6
5
8
8
7
8
6
4
5
6
7
4
4
5
6
West
6
5
5
5
5
6
3
6
4
2
6
3
5
2
1
2
6
5
2
2
2
2
2
1
3
1
2
2
1
2
2
1
1
2
3
2
5
2
2
1
1
2
0
1
1
2
3
1
3
1
2
1
2
0
1
1
1
1
1
1
0
'1
1
2
Number of
Occurrences
In Blanks
4
1
3
0
0
3
1
3
0
0
3
1
1
0
0
0
3
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
2
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
1
0
0
0
40
-------
Table 9 (continued)
Index
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
Average
RRT
2.088
0.996
1.027
0.218
0.398
1.475
1.522
1.542
1.980
0.745
0.904
1.105
1.359
0.429
0.673 .
0.897
1.548
1.989
0.226
0.243
0.989
1.149
1551
1.973
£151
2.174
0.301
0.392
0.520
0.672
1.198
1.675
1.889
0.492
0.758
1.175
1.202
1.308
1.472
1531
1.966
2.137
1531
0.374
0.450
0.540
0.547
0.559
0.573
0.762
0.918
1.062
1.070
1.105
1.138
1.175
1.288
1.460
1.716
1.729
0.475
0.507
0.520
0.667
Total Number
of Occurrences
12
11
11
11
11
11
11
11
11
10
10
10
1C
9
9
9
9
9
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7.
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5 .
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
Number of Occurrences in Each Region
North Central Northeast South
4
2
2
2
3
4
3
3
4
3
3
2
3
5
4
2
3
4
2
2
4
3
4
4
2
2
2
2
0
1
2
2
1
3
3
3
1
1
1
3
1
1
1
.1
1
1
1
1
1
2
3
0
2
1
3
2
0
1
1
2
1
0
0
3
2
3
3
3
2
3
2
2
1
1
1
3
3
1
2
1
2
0
2
2
0
2
0
0
1
1
0
1
6
0
0
0
2
2
1
0
0
2
0
0
2
1
0
1
2
0
1
1
0
0
0
1
0
2
0
3
2
1
1
1
1
1
1
0
5
5
5
4
6
4
4
5
5
6
5
4
4
2
3
5
3
5
2
2
3
3
3
4
4
5
2
3
0
5
5
4
3
0
2
3
4
3
3
3
3
3
3
2
2
4
3
3
3
3
2
3
2
2
2
0
2
2
3
2
1
3
2
1
West
1
1
1
2
0
0
2
1
1
0
1
*1
0
1
0
1
1
o
2
2
1
0
1
o
1
0
3
1
1
1
0
1
1
1
0
0
1
o
2
0
0
1
1
•j
o
o
o
o
c
0
1
1
o
o
o
1
1
o
0
1
o
1
0
Number of
Occurrences
in Blanks
0
1
1
0
0
0
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
V
1
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
0
41
-------
Index
128
129
130
131
132
133
134
135
135
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
Average
RRT
0.721
0.832
0.936
1.C61
1.109
1.153
1.173
1277
1.328
1580
1.927
1.979
2.00C
0.319
0.375
0.609
0.307
0.346
0.353
0.487
0.727
0.739
0.790
0.821
0.828
1.083
1.119
1.123
1.195
1.309
1.404
1.448
1.538
1.856
1.953
2.084
aoai
0512
0.572
1.809
1.900
0.237
0561
0.337
0.341
0.342
0.382
0.413
0.435
0.450
0.489
0.496
0.552
0.599
0.614
0.677
0.758
0.791
0.908
0.921
0.957
1.059
1.261
1283
Total Number
of Occurrences
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Table
9 (continued)
Number of Occurrences in Each Region
North Central Northeast South
0
0
1
1
2
0
2
1
0
2
2
1
2
2
1
1
0
1
0
1
0
1
0
0
0
0
1
2
0
0
1
0
1
2
2
2
1
2
0
0
0
1
0
1
0
1
0
0
1
1
0
0
1
0
0
0
1
1
1
0
1
1
1
0
0
0
1
1
1
2
0
1
0
1
0
1
0
0
1
0
0
1
0
0
0
1
2
1
1
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
.0
0
2
0
2
0
0
0
0
0
0
0
0
2
2
2
0
0
0
0
0
0
0
1
4
4
1
2
0
2
2
2
4
0
1
1
2
1
0
2
2
1
0
2
3
0
0
2
2
3
2
1
3
2
1
2
2
1
1
1
2
0
2
2
2
1
0
1
0
1
1
2
0
1
2
2
1
0
0
0
0
1
1 •
2
1
1
1 ,
1
West
0
0
1
0
1
0
0
0
0
1
1
1
0
0
1
0
1
0
3
0
0
1
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
1
0
0
0.
0
0
0
0-
Number of
Occurrences
in Blanks
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
o
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
.0
0
0
42
-------
Index
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
Average
RRT
1291
1297
1.353
1.463 ,
1.507
1516
1.525
1.586
1.594
1.673
1.866
1531
2.030
2.102
0.333
0.544
0.199
0.203
0.216
0.221
0.239
0.240
0.241
0.254
0.266
0.268
0.283
0.285
0.293
0.300
0.327
0.344
0.352
0.353
0.358
-•0.359
0.362
0.365
0.370
0.371
0.372
0.394
0.405
0.414
0.419
0.421
0.422
0.455
0.463
0.465
0.504
0.507
0.510
0.516
0.545
0.575
0.584
0.652
0.653
0.678
0.683
0.711
0.744
0.745
Total Number
of Occurrences
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1 .
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Table
9 (continued)
Number of Occurrences in Each Region
North Central Northeast South
0
1
1
1
0
0
1
1
2
2
0
1
1
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
o .
0
0
0
1
0
0
0
0
0
1
1
1
1
0
0
0
1
0
0
0
1
0
0
0
1
1
0
0
0
0
0
0
1
1
0
1
0
0
0
0
0
1
0
1
1
0
0
0
0
0
1
0
0
0
0
1
0
c
1
0
0
0
0
0
1
0
1
0
0
0
2
1
1
0
1
1
0
1
0
0
1
1
1
1
0
1
1
1
0
0
1
1
0
0
1
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
1
1
1
0
1
1
1
0
0
0
0
0
1
1
1
0
1
0
1
0
0
0
1
West
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
o
0
o
0
0
o
o
o
o
o
1
o
1
1
o
•)
o
o
•)
o
o
o
o
o
o
o
o
o
o
1
1
o
o
o
o
1
0
o
o
. o
o
•)
0
Number of
Occurrences
in Blanks
0
0
o
o
0
0
o
0
0
0
o
o
o
o
•\
1
0
0
0
o
o
o
o
n
u
o
o
o
o
o
o
o
Q
o
n •
V
o
o
V
o
o
V
o
o
o
o
o
v
Q
n
u
o
o
o
n
w
o
o
o
g
o
n
V
o
n
V
o
n '
\l
o
0
43
-------
bxJsx
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
319
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
Average
RRT
0.767
0.771
0.775
0.779
0.786
0.787
0.821
0.915
0.929
0.945
0.960
0.988
1.017
1.018
1.037
1.046
1.061
1.C63
1.070
1.089
1.091
1.112
1.121
1.140
1.174
1.180
1.197
1.204
1.204
1218
1.223
1.226
1.243
1.248
1289
1291
1296
1.309
1511
1.335
1.342
1.346
1.348
1.350
1.363
1.366
1.377
1.384
1.386
1.390
1.403
1.421
1.422
1.427
1.433
1.435
1.457
1.481
1.492
1.495
1.499
1523
1.525
1531
Tola] Number
of Occurrences
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Table
9 (conti
nued)
Number at Occurrences in Each Region
North Centra! Northeast South
1
0
0
0
0
0
0
0
0
0
0
c
0
c
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
1
1
0
1
0
1 . •
1
1
0
1
0 '
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
,1 .
1
0
1
1
1
1
1
0
1 •
1
1
0
1
1
'1
1
1
1
0
0
1
1
1
1
1
1
1
1
1
0
1
1
1
1
1
0
1
1
1
1
1
1 .
1 •
1
1
1
0
0
1
0
0
1 .
0
1
0
0
0
1
0
West
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
. 0
0
0
0
0
0
0
0
0
0
0,
0
0
0
0
0
0
0
0
0
0
0 .
0
0
Number of
Occurrences
in Blanks
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
•0
0
0
0
o-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44
-------
Index
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
Average
RRT
1.545
1.562
1.583
1.584
1.589
1.596
1.602
1.606
1.607
1.671
1.695
1.740
1.761
1.762
1.776
1.839
1.907
1.964
1.973
1.980
1.991
2.053
2.063
2.107
Total Number
of Occurrences
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Table
9 (concluded)
Number of Occurrences in Each Region
North Central Northeast South
1
1
1
1
1
1
1
1
1
0
0
0
0
0
1
1
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
1
1
0
0
1
1
1
0
1
1
1
0
West
0
0
0
0
0
0
0
0
0
o
0
o
o
0
0
0
o
0
o
o
0
o
0
0
Number of
Occurrences
in Blanks
0
0
0
0
0
0
0
0
0
0
0
0
o
0
0
0
0
o
o
o
0
o
o
0
45
-------
Tab!
We*
1
2
3
&
5
6
7
8
9
1C
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
33
39
40
41
42
43
44
45
46
e 10. NHATS
SarrcteName
1-EN-VO-0-14
1-EN-VO-15-44
1-EN-VO-45+
1-ES-VO-0-14
1-ES-VO-15-44
1-ES-VO-45+
1-MA-VO-0-14
1-MA-VO-15-44
1-MA-VO-45+
1-MO-VO-0-14
1-MO-VO-15-44
1-MO-VO-45,.
1-NE-VO-0-14
1-NE-VO-15-44
1-NE-VO-45+
1-PA-VO-0-14
1-PA-VO-15-44
1-PA-VO-45+
1-SA-VO-0-14
1-SA-VO-15-44
1-SA-VO-45+
1-WN-VO-0-14
1-WN-VO-15-44
1-WN-VO-45+
1-WS-VO-0-14
1-WS-VO-15-44
1-WS-VO-45+
2-EN-VO-0-14
2-EN-VO-15-44
2-EN-VO-45+
2-ES-VO-15-44
2.ES-VO-45+
2-MA-VO-0-14
2-MA-VO-15-44
2-MA-VO-45+
2-SA-VO-0-14
2-SA-VO-15-44
2-SA-VO-45+
2-WN-VO-45+
2-WS-VO-15-44
3-EN-VO-15-44
3-EN-VO-45-1-
3-SA-VO-15-44
3-SA-VO-45+
4-SA-VO-15-44
4-SA-VO-45+
FY82 Comoosite
Number of Peaks
Submitted to
ACORN Program
68
63
62
51
43
49
61
54
60
49
45
50
48
53
54
52
56
68
56
58
44
57
59
70
54
61
60
55
70
68
59
53
56
58
52
58
59
67
45
64
59
68
58
62
53
50
Peak Inventory -
Number of Compounds
Identified by
ACORN Program
48 •
42
45
35
26
35
42
35
40
33
30
32
36
35
34
38
42
47
41
39
30
40
42
46
36
43
40
37
47
49
40
36
38
39
32
39
43
47
31
42
43
46
40
42
38
33
Volatile Organic
Number of Unidentified
Peaks RemaJnhg
20
21
17
16
17
14
19
19
20
16
15
18
12
18
20
14
14
21
15
19
14
17
17
24
18
18
20
18
23
19
19
17
18
19
20
19
16
20
14
22
16
22
18
20
15
17
Analysis Data Set
Number of Compounds
Identified by Target
Corocund Analysis
23
23
22
21
21
21
23
24
23
1 21
24
22
22
23
21
22
24
23
21
23
22
22
£>&
22
Cm£t
24
20
20
21
*
22
£•£,
24
t*T
22
25
£*J
24
23
CtJ
24
&*T
22
22
24
24
22
?d
£*T
23
fcW
23
23
£w
23
21
" *
19
46
-------
Table 11. NHATS FY82 Composite Peak Inventory - 6% Florisil
Semivolatile Organic Analysis Data Set
index
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
Number of Peaks
Submitted to
Sample Name ACORN Program
1-EN-SVO-0-14
1-EN-SVO-15-44
1-EN-SVO-45+
1-ES-SVO-0-14
1-ES-SVO-15-44
1-ES-SVO-45+
1-MA-SVO-0-14
1-MA-SVO-15-44
1-MA-SVO-45+
1-MO-SVO-0-14
1-MO-SVO-15-44
1-MO-SVO-45+
1-NE-SVO-0-14
1-NE-SVO-15-44
1-NE-SVO-45+
1-PA-SVO-0-14
1-PA-SVO-45+
1-SA-SVO-0-14
1-SA-SVO-15-44
1-SA-SVO-45+
1-WN-SVO-0-14
1-WN-SVO-15-44
1-WN-SVO-45+
1-WS-SVO-0-14
1-WS-SVO-15-44
1-WS-SVO-45+
2-EN-SVO-0-14
2-EN-SVO-15-44
2-EN-SVO-45+
2-ES-SVO-45+
2-MA-SVO-0-14
2-MA-SVO-15-44
2-MA-SVO-45+
2-SA-SVO-0-14
2-SA-SVO-15-44
2-SA-SVO-45+
2-WN-SVO-45+
2-WS-SVO-15-44
3-EN-SVO-15-44
3-EN-SVO-45+
3-SA-SVO-15-44
3-SA-SVO-45+
4-SA-SVO-1 5-44
4-SA-SVO-45+
50
63
79
55
50
54
50
36
54
37
66
64
45
31
82
48
59
79
79
80
55
36
54
54
43
58
49
45
73
72
46
36
49 ,
59
50
77
72
46
52
70
50
59
49
56
Number of Compounds
Identified by
ACORN Program
16 '
19
21
22
24
26
16
13
26
17
23
23
16
14
28
18
22
34
23
31
14
13
27
14
13
25
14
15
17
22
17
9
16
16
14
24
18
13
12
22
14
27
17
20
Number of Unidentified
Peaks Remainfig
34
44
58
33
26
28
34
23
28
20
43
41
29
17
54
30
37
45
56
49
41
23
27
40
30
33
35
30
56
50
29
27
33
43
36
53
54
33
40
43
36
31
32
36
Number of Compounds
Identified by Target
10
1Q
15
14
26
34
w*t
22
22
28
21
•ti
15
23
10
y^
£O
19
13
20
23
tM
24
24
20
&V
26
CM
37
15
26
fcU
31
?n
£U
33
32
v\
£O
25
CfJ
18
n
1 0
")")
££
23
22
16
1Q
i a
28
33
X
y*
CO
32
47
-------
Table 12. NHATS FY82 Composite Peak Inventory - 15/50% Florisil
Semi volatile Orqanic Analysis Data Set
Index
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
Number of Peaks
Submitted to
SamDfeNams ACORN Proaram
1-EN-SVO-0-14
1-EN-SVO-15-44
1-EN-SVO-45+ •
1-ES-SVO-0-14
1-ES-SVO-15-44
1-ES-SVO-45+
1-MA-SVO-0-14
1-MA-SVO-1544
1-MA-SVO-45+
1-MO-SVO-0-14
1-MO-SVO-15-44
1-MO-SVO-45-S-
1-NE-SVO-O-U
1-NE-SVO-15-44
1-NE-SVO-45+
1-PA-SVO-0-14
1-PA-SVO-15-44
1-PA-SVO-45+
1-SA-SVO-O-H
-SA-SVO-15-44
-SA-SVO-45+
-WN-SVO-0-14
-WN-SVO-15-44
-WN-SVO-45+
1-WS-SVO-0-14
1-WS-SVO-15-44
1-WS-SVO-45+
2-EN-SVO-0-14
2-EN-SVO-15-44
2-EN-SVO-45+
2-ES-SVO-15-44
2-ES-SVO-45+
2-MA-SVO-0-14
2-MA-SVO-15-44
2-MA-SVO-45+
2-SA-SVO-0-14
2-SA-SVO-15-44
2-SA-SVO-45+
2-WN-SVO-45+
2-WS-SVO-15-44
3-EN-SVO-15-44
3-EN-SVO-45+
3-SA-SVO-15-44
3-SA-SVO-45+
4-SA-SVO-15-44
4-SA-SVO-45+
75
67
60
78
68
91
59
33
41
57
75
73
48
24
58
38
38
57
97
68
94
79
60
91
66
68
96
108
73
102
22
52
83
.65
99
88
73
129
78
79
46
80
57
77
' 57
22
Number of Conpounds
Identified by
ACORN Program
21
20
19
14
15
18
20
12
21
20
19'
16
15
11
24
13
13
16
26
20
29
24
12
27
22
16
23
24
15
21
6
9
21
18
28
24
15
30
20
20
15
16
14
18
16
6
Number of Unidentified
Peaks Remaning
54
47
41
64
53
73
39
21
20
37
56
63
33
13
34
25
25
41
71
48
65
55
48
64
44
52
73
84
58
81
16
43
62
47
71
64
58
93
58
59
31
64
43
59
41
16
Number of Compounds
Identified by Target
Corrcound Analysis
2 -
1
2
6
7
1
2
4
3
1
3
4
3
3
3
1
'1
3
2
2
3
4
4
5
6
5
6
6
7
,6
1
1
4
4
4
5
6
6
5
3
1
5
5
2
1
1
48
-------
Each of the samples analyzed is identified under Sample Name. The sample
name code includes a number to indicate the number of composites analyzed
within -a specific age group in a designated census division. For example,
the code l-EN-VO-14 indicates that this is the first composite from the East
North Central (EN) census division representing the 0-14 age group. The code
VO designates, the composite was analyzed for volatile organic compounds. Each
of the nine census divisions are represented in the tables (EN = East North
Central; ES^= East South Central; MA = Middle Atlantic; NE = New England;
SA = South Atlantic; WN = West North, Central; WS = West South Central; MO =
Mountain; and PA = Pacific).
Additional tables detailing the frequency of occurrence of HRGC/MS
responses are 'included in Appendices -A through F, provided as a separate vol-
ume with this report. The information in these tables is identical to that
provided in the previously described data tables (1 through 9). However, in-
cidence of occurrence information is provided for the nine census divisions
in addition.to four census regions and three age groups. The tables in Ap-
pendices A through C are "dot matrix" tables displaying the incidence of oc-
currence of identified compounds for each of the samples analyzed in this
study. Compound names are sorted in the same order as Tables 1 through 3.
Sample data are arranged in a matrix of census region, census division, and
age group. Each table in the:appendices is devoted to a particular census
region. The four census regions which are represented are the West, South,
North Central, and Northeast.
Tables in Appendices D through F are "dot matrix" tables displaying
the incidence of occurrence of unidentified compounds for each of the samples
analyzed in this study. The tables in these appendices are organized identi-
cally to the tables in Appendices A through C.
V. DISCUSSION
This section provides a discussion of the limitations of the identi-
fication method and limitations of the FY82 data set.
A. Limitations of the Peak Identification Method
Discussions of the limitations to the peak identification method
may be divided into two categories: limitations of the implementation of the
method and limitations inherent to the method itself.
The primary concern regarding the implementation of the method was
that it was not fully automated. A number of critical steps could have bene-
fited from additional computer programming. The manual review process in
particular was very time-consuming because all corrections to the seed library
.had to be made "by hand," i.e., an operator was required to make manual cor-
rections to the summary report, identification list, and seed library. Spread-
sheet generation also proved to be more .time-consuming than originally antici-
pated. However, in spite of these limitations, the actual results of the
procedure were not affected.
49
-------
Inherent limitations of the identification scheme were more subtle.
Certainly the most stringent limitation in this respect was the dependence of
the program on high quality spectra. Unknown mass spectra with distinctive
fragmentation patterns, acceptable signal strength, and no contamination^from
coeluting peaks were easily identified. Conversely, spectra with very little
fragmentation, poor or excessive signal strength, or significant contamination
were a constant problem.
This dependence upon quality mass spectra is not peculiar to this
method. It is a necessary condition for the interpretation of mass spectra_
in general, whether automatic or manual. No method of automatic peak identi-
fication can be successful unless analytical conditions are optimzed for the
generation of high quality mass spectra.
It should be emphasized that a manual review was performed for each
compound tentatively identified in this report. In cases where identification
to a specific compound isomer could not be conclusively determined, a non-
specific compound or compound class name was reported. However, the full
name of the best ranked NBS reference compound was also retained and reported
in brackets.
B. Limitations of the FY82 Data
In addition to the limitations of the identification method de-
scribed above, there were limitations with the FY82 adipose datafiles them-
selves when applied to the area of unknown peak identification. Most of
these limitations stem from using GC/MS operating parameters which were
optimized for target compound analysis rather than interpretation of unknown
mass spectra. Three GC/MS operating parameters were identified which had an
effect on the performance of the peak identification method: (1) sensitivity
setting of the mass spectrometer; (2) mass scanning range of the mass spec-
trometer; and (3) temperature program rate of the HRGC. Background contribu-
tion also had an effect on the performance of the peak identification method.
Each of these parameters is discussed below.
1. MS Sensitivity
The objective of the broad scan target compound analysis for the
FY82 samples was to quantitate target compounds in the 50 to 100 ppb (ng/g)
range. This sensitivity range is common in routine target compound analysis.
Mass spectrometric'response may be considered to be roughly proportional to
concentration for a given sample type such as volatile or semi volatile. Also,
the dynamic range of a mass spectrometer is approximately two orders of magni-
tude for quantisation and slightly higher for reliable mass spectral interpre-
tation of unknown compounds. Spectra observed at sensitivities outside this
range may not be adequate for identification purposes due to saturation at
the high end and excessive noise or signal dropoff at the low end of the
range. These estimates are quite general, with each compound having its own
HRGC and MS performance characteristics.
Unfortunately, the organic matrix in the adipose samples of both
the volatile and semivolatile data sets was very complex. At sensitivity
50
-------
LIBRARY SEARCH DATA: 7901F19M1 tt 358
06/19/84 16:52:80 * 5:58 CALI: CALF19H1 tt 3
SAMPLE: »301-l-PA-UO-8-14,-H.8UG 1.5. 4- 1.6UG DEIJT.STI).
COUDS.i -1850EIW 10-7SENS .3MA DB5-30H 30-5H-125-6/ 10:1SPL UES@95 CR6RT
BASE M/Z: 41
RIC: 6168570.
1295
SAMPLE
C6.H12.0
1295 i
H HT IBB
I 1294
PUR 88?
r
/•
/
X
HEXf)
r
'
LJ
1 1 . ll . .
HAL
- . • . . . t . . . —
1295
en
-1295
M/Z
SAMPLE MINUS LIBRARY
II
i I.
T*~
58
£.0
70
80
90
100
110
Figure 8. Example of degradation of mass spectral quality as a result of instrument saturation.
The upper spectrum'is taken from a peak which saturated the mass spectrometer. Tick marks
above the mass histograms indicate ions which are saturated. The lower plot is the NBS
reference mass spectrum for the compound.
-------
settings required to keep the target compounds within the desired quantita-
tion range, many unknown peaks had responses well outside the range necessary
for reliable mass spectral interpretation. Figure 8 illustrates the effects
of acquiring mass spectra at sensitivity settings inappropriate for mass spec-
tral interpretation purposes. In this example, the results of an NBS library
search of an unknown spectrum are shown. The mass spectrum at the top of the
page shows the unknown spectrum. Tick marks above some of the masses indicate
signal saturation. The spectrum immediately below the unknown spectrum is
the best candidate chosen from the NBS library. Note that there is a marked
change in the relative intensities of many of the saturated masses. , Although
in this case saturation did not prevent the NBS library search from choosing
the correct candidate, other cases resulted in ACORN incorrectly identifying
the unknown peak. Manual review of the data after each application of ACORN
corrected these misassignments.
2. Scan Range Selection
The semivolatiles presented an additional problem which was related
to the original MS operating parameters. The semi volatile samples were ac-
quired using a mass range suitable for the detection of molecular clusters
characteristic of chlorinated benzenes and polybrominated compounds such as
polybrominated biphenyls. This required setting the mass spectrometer to
scan in the high mass region (100-700 amu). A Finnigan/MAT 311A magnetic
sector mass spectrometer was chosen for the analysis. Due to design con-
straints of magnetic mass spectrometers of this type, it was necessary to
begin the mass scan at 100 amu in order to achieve an upper mass limit of
700 amu. Unfortunately, many compounds have significant mass fragmentation
in the 30 to 100 amu mass range. Fragmentation in this low mass region is
often of critical importance in correctly identifying a compound. Thus, the
quality of semivolatile spectra was often marginal for reliable mass spectral
interpretation purposes.
This problem was most acute for compounds with a molecular weight
between 100 and 150 amu. In these cases there was often insufficient frag-
mentation to confirm the comparison with the NBS library. The effect of poor
fragmentation on library search results is shown in Figure 9. The format of
this output is identical to one shown previously in Figure 2. In this example,
note that a number of compounds of varying elemental formulas were selected
from the NBS library as likely candidates. However, the graphic comparison
of the unknown to the three best candidates indicates that only one major peak
at m/z 108 and three minor peaks clustered around the major peak were present
in the unknown spectrum. It is also apparent from the graph that there is
insufficient evidence to assign this spectrum to any of the candidates, as
indicated by the close similarity of the unknown spectrum to the three best
candidate spectra.
3. HRGC Temperature Program
The broad scan analysis of the FY82 composite samples was optimized
for the most rapid turnaround time possible without sacrificing the quality
of the target compound quantitation results. This was accomplished by using
relatively fast GC temperature program rates (6°C/min for volati'les, 10°C/min
52
-------
Utr.rv Btareft Data: 79O1F13BI • 179 Ba» a/1' 1O8
06/13/84 10:30:00 » 3:S3 Call: CALF13R3 t 2 RIC: 229887.
Saapla: 79OI-S-O32. 6X. 2-«A-SVO-O-14. 1UL INJ (2UG D-10 ADDED)
Condi.: -1630EHV, 7QEV. 1HA. DB3-30H-60-2H-310-10. 43 SEC SPLITLESS
42222 spectra in LIBRARYN8 searched for Miami* PURITY
438 Batcbet at least 4 of tbe 11 largest peak* In the unknowi
Refuction: Pks/lOO u : 4Oj Win«o..: 30. 7
Pr»—ftaareh: Entries to pass: 2OOi Ba«pl« gis: 99 - SSOi Hor« tnt: 2Si Ratio factors: a. 0, I. (
Rank In. Naav
1 1776 HYORAZINE. PHENYL-
3 1778 1.3-BENZENCOIAnlNE
3 6496 PYRIDINlUrl, l-«1INO-4-«ETHYL-. CHLORIDE
4 1891 1H-FYHROLE. 2. 3. S-TRIHETMY1.-
S 1779 1.2-1ENZENEDIM1INE
a 781S 3-CYCUOPENTENE-l-ACETALDEHYDE. 2.2.3-TRInETHYL-
7 1BS4 CYC1.OPENTE^E. 3-ETHYUIDENE-l-rCTHYl.-
B 17B2 PYRIMIDINE. *. J-D1BETHYI.-
9 17B6 I-PYRIDINAHINE.
Rant
1
2
3
4
9
C6. HS. N3
C6. Ha. N2
C4. H9. N2 CL
C7. HU.N
C6. HS. N2
CIO. H16. 0
CS.H12
C6. KB. N2
C*. Hfl. MS
H. Ut B. P» Purltv Fit RFlt
108 1OS 948 967 948
10a 108 946 964 946
144 93 938 936 938
1O» 1O8 937 943 937
108 108 934 938 924
1S2 108 922 940 981
108 93 920 934 9BO
108 1O8 914 9T2 914
108 1O8 847 8U4 867
1134
SfWLE
CS.H8.N2
LIBRARY SB5RW DBTAl 7«ain3Rl I 179
es/ia^4 !9:38iee * 2:53 WLII cafisa • 2
SSWLE: 7581-9-652,C?.2-«»-SUO-«-!4,lUL IHJ (2UG 0-1« OXSB)
CCNCS.l -!STK?W,78E«,l«R.CSS-38rr€8-3f-318-19,« SE SPUTUSS
BASE IVHi 188
RICl 22988?.
CS.K9.H2.O.
PYRIDIHIUB, l-vmlNO-4-ferHYl.-, OtURIDE
18!
Ill
UJ
129
123
138
Figure 9. Library search results of an unknown peak with inadequate fragmen-
tation for reliable identification. The upper plot in the lower figure is
the mass spectrum of the unknown peak. Note that only four masses are
present in the unknown spectrum. Poor fragmentation often results in
multiple candidate spectra, as shown in the upper portion of the figure.
53
-------
for semivolatiles) to compress the GC profile as much as possible. Unfortu-
nately, this caused a number of unknown peaks to overlap and coelute.
The Incos data system contains enhancement software which attempts
to deconvolute mixed spectra, but its success is dependent on the degree of.
overlap of the various GC peaks. As the overlap becomes greater and the num-
ber of overlapping compounds increases, the enhancement routine becomes less
successful in deconvoluting spectra. Peaks with complete or nearly complete
overlap cannot be deconvoluted at all.
The ACORN procedure always used enhanced spectra when conducting
searches of the seed and NBS libraries. Despite this precaution, however, a
number of mass spectra were analyzed which upon closer examination were found
to be mixtures of two or more compounds. There did not appear to be a solu-
tion to this problem using the available data. Different operating conditions
could be employed to optimize the analysis for unknown compound identification
purposes. These could include a slower GC temperature program rate, use of a
longer capillary column, or use of a Megabore column for volatile analysis.
Of course, these changes would require reanalysis of at least a limited number
of samples.
4. Background Contribution
A number of samples in the semivolatile fraction exhibited a hump-
shaped RIC profile, shown in Figure 10, which is common for samples of bio-
logical origin. The hump exhibits a rather uniform spectrum throughout its
entire length, which is shown in Figure 11. The presence of this hump
throughout a major portion of the RICs interfered with attempts to extract
high quality spectra of peaks located on the humps. The effect of the hydro-
carbon hump was least acute for samples in the 0-14 age group and progres-
sively influenced data quality in the higher age group samples. Figure 6,
which was presented earlier in this text, illustrates the difference in the
intensity of the hydrocarbon hump in proceeding from the 0-14 age group to
the 45+ age group.
54
-------
iea.a-1
R1C DATA: P381D66R5 »1
84/66/84 16:45:68 CALIs CAL086R3 12
SAMPLE: 7981-8-949 67. l-MA-SUO-8-14 1UL
COHDS.: -1606EMU 78EU Ittfl 085-38(1-69-2H-318-18/ 45 SEC.
RANGE: G 1,1588 LABEL: H B, 4.8 QUAH: A 0. 1.8 J
783
SCANS
1 TO 1508
SP1.ITLESS
3 BASE: U 28,
427
3 3
R1C
11?
186
1
288
5:48
625664.
781
527
488
1819
1858
1176
1328
468
11:28
—I
£88
17:68
—I
868
22:48
1808
28:28
1268
34:68
1408
39:48
SCAN
TIME
Figure 10. RIC chromatogram with hydrocarbon "hump.
55
-------
-------
TECHNICAL REPORT DATA
(Please read Insir.icrions on the reverse before completing
1. REPORT NO. 2.
FPA-5fin/5-.R7-DQ2A
A. TITUS AND SUBTITLE
Characterization of HRGC/MS Unidentified Peaks from
the Analysis of Human Adipose Tissue, Volume I -
Technical Approach
7. AUTHOR(S)
J. D. Onstot, R. E. Ayling, J. S. Stanley
9. PERFORMING ORGANIZATION NAME AND ADDRESS
Midwest Research Institute
425 Volker Boulevard
Kansas City, MO 64110
12. SPONSORING AGENCY NAME ANO ADDRESS
U.S. Environmental Protection Agency
Office of Toxic Substances (TS-798)
Field Studies Branch, 401 M Street, S.W.
Washington. DC ?D460.
3. RECIPIENT'S ACCSSSlON»NO.
S. REPORT DATE
June 30. 1987
6. PERFORMING ORGANIZATION CODE
Midwest Research Institute
8. PERFORMING ORGANIZATION REPORT
8823-A(01)
10. PROGRAM ELEMENT NO.
Work Assignment 23
11. CONTRACT/GHAN t NO.
68-02-4252
13. TYPE OF REPORT ANO PERIOD COVE;
Final Report 1/86-1/87
14. SPONSORING AGENCY CODE
EPA/OTS/FSB
15. SUPPLEMENTARY NOTES
The National Human Adipose Tissue Survey (NHATS), administered by EPA/OTS, is an on-
going chemical monitoring network designed to detect levels and prevalences of toxic
substances in the adipose tissue of the general U.S. population. Adipose specimens
:ollected in fiscal year 1982 were analyzed as composites for volatile and semi vola-
tile organic compounds via HRGC/MS as part of a previous effort. The data files were
then processed using a method developed to automatically identify unknown HRGC/MS
peaks. The method consisted of automatic identification of unknown spectra via com-
parisons to reference mass spectra, transfer of the results of the identification
step to a microcomputer, compilation of the data into a spreadsheet program and gen-
eration of compound identification tables from the spreadsheet. Application of the
method to the adipose data resulted in the identification of volatile compounds from
18 separate chemical classes and semivolatiles from 29 chemical classes. Compound
classes included saturated and unsaturated hydrocarbons, aldehydes, ketones, steroids
heterocyclic compounds, drugs, aliphatic and phthalate esters, phenols, halocarbons,
and methyl-substituted organosiloxanes. Volume I (EPA-560/5-87-002A) describes the
technical approach. Volume II (EPA-560/5-87-002B) provides supplemental data.
17
-------
-------